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ABSTRACT
Singh, Amanpreet. Ph.D., Biomedical Sciences Ph.D. Program, Wright State University,
2016. Novel Cell Killing Mechanism of Hydroxyurea in the Fission Yeast
Schizosaccharomyces pombe and Its Implications in Improving Antifungal Therapy.

Hydroxyurea (HU, also known as hydroxycarbamide) is a well known ribonucleotide
reductase (RNR) inhibitor that depletes cellular deoxyribonucleoside triphosphates
(dNTPs, the building blocks of DNA). Depleted dNTP pools inside the proliferating cells
stalls ongoing DNA replication forks, leading to the activation of the well-conserved
DNA replication checkpoint (also known as intra-S phase checkpoint) pathway. One of
the major functions of the checkpoint pathway is to protect ongoing forks from
collapsing. Stalled forks, if not protected by the checkpoint pathway, lead to DNA
damage and ultimately cell death. Thus it is believed that DNA damage resulting from
collapsed forks is the underlying cause of cell death induced by HU, although HU may
kill the cells by other mechanisms. This dissertation focuses on defining a novel cell
killing mechanism of HU in the fission yeast Schizosaccharomyces pombe. A mutation
has been identified in hem13+ encoding coproporphyrinogen III oxidase, an essential
enzyme involved in the heme biosynthetic pathway that significantly sensitizes the cells
to HU. We found that the HU sensitivity of the hem13 mutant is a consequence of
increased production of reactive oxygen species caused by HU treatment, not the
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DNA damage generated by fork collapsing. This newly identified cell killing mechanism
of HU in hem13 mutant has great implications in antifungal therapy.
The first part of this dissertation focuses on the discovery of the novel hem13 mutant in S.
pombe using genetic screening. The second part rules out the possibility of a checkpoint
defect in the screened mutant. The third part describes oxidative stress as the novel cell
killing mechanism of HU in hem13 mutant. In the last part, we show the strong
synergistic cell killing effect of sampangine (SMP), an inhibitor of heme synthesis and
HU in S. pombe, S. cerevisiae and the pathogenic fungus Candida albicans.
Taken together, this dissertation defines a novel cell killing mechanism of HU in S.
pombe and the synergistic effect of HU and SMP in suppressing cell growth of wild type
S. pombe, S. cerevisiae and pathogenic fungus C. albicans.
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INTRODUCTION
DNA replication in eukaryotes
One of the most challenging and highly regulated processes occurring inside living cells
is DNA replication. DNA replication is challenging because the replisome has to deal
with many obstacles such as chromatin packaging, specialized DNA structures,
transcription machinery and damaged DNA. Tight regulation is required to ensure that all
chromosomes are replicated only once per cell cycle. Under or over replication of the
genome can have deleterious consequences for the cell and lead to a number of genetic
diseases in humans including cancer, birth defects and many developmental
abnormalities (1).

Initiation of DNA replication in mammals
DNA replication proceeds with a process called unwinding or melting that causes the two
strands to separate. Strand separation allows DNA polymerases to copy DNA by
synthesis of new DNA chains on both strands. The unwinding process begins at multiple
specific sites along the chromosomes in all eukaryotes. These specific sites are termed as
the replication origins. The DNA replication origins are bound by multi-protein complex
including the Origin Recognition Complex (ORC) and two additional proteins, Cdc6 and
Cdt1 (2). This multi-protein complex aids in the recruitment of the replicative helicase,
the Mcm2-7 complex and this recruitment process requires ATP. This step is referred to
as the licensing or pre-replication complex (pre-RC) formation. Mcm2-7 complex is
1

loaded on DNA as a head-to-head double hexamer (3,4). In metazoans, this pre-RC
formation is blocked by geminin protein, which interferes with the activity of Cdt1 (5,6).
A Mcm2-7- related protein, Mcm8, has also been implicated in pre-RC formation in
Xenopus (7).
The loading of Cdc45 and the GINS complex, onto the pre-RC marks the formation of
pre-initaition complex (pre-IC). The assembly of these factors requires the activity of
Cyclin-Dependent Kinases (CDK). CDK inhibitors such as p21 or p27 can specifically
inhibit this step. Phosphorylation activity of Cdk is required to activate key components
of pre-IC. One of the components of pre-IC complex, Cdc45, is required for the
recruitment of DNA polymerases α and δ at the replication origins (8-10). Mcm2-7
complex has been shown to physically interact with Cdc45 and GINS complex (11). The
resulting CMG complex is believed to be the active form of the replicative helicase. It
has been shown that the Cdc7 protein kinase in complex with Dbf4 (its regulatory
subunit) phosphorylates Mcm2-7 complex subunits, thereby resulting in a conformational
change in the helicase complex (12,13). Phosphorylation of two additional proteins Sld2
and Sld3 by DDK is also required in the formation of pre-IC complex (14,15). This
phosphorylation is involved in regulating complex formation between Dpb11, Sld2, Sld3,
GINS and DNA polymerase ε (14-16). Thus, pre-IC complex formation marks the
loading of active CMG helicase complex and additional components required for DNA
replication.
Once the helicase is activated, it begins unwinding of DNA. The unwinding process
generates stretches of single-stranded DNA (ss-DNA) bound by the replication protein A
(RPA). The RPA binding stimulates the DNA polymerase activity onto ss-DNA (10,17).
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Unwinding of DNA by Mcm2-7 helicase also generates topological stress in front of the
fork. Topoisomerases, the specialized enzymes that can cleave and reseal DNA, reduces
this stress. RPA coated ss-DNA is now able to recruit DNA polymerase α/primase. This
polymerase is unique in that it can initiate DNA synthesis in the absence of 3’ hydroxyl
end. The enzyme has primase activity that is capable of synthesizing short ribonucleotide
chains, which can further be extended by catalytic subunit of the enzyme. Later
polymerase δ takes over whose processivity is very high due to the associated
proliferating cell nuclear antigen (PCNA) clamp with it that strongly stimulates its
polymerase activity. PCNA comprises of a homotrimeric ring that is loaded onto DNA by
its specific loader RF-C complex. The specific loader aids in the opening of the PCNA
ring in an ATP dependent manner and loads it around the DNA (18). In yeast, a third
DNA polymerase pol ε has been identified which functions to replicate the leading
strand. Thus formation of the initiation complex leads to the loading of the replicative
polymerases.

Elongation and Termination
Once the replicative polymerases are loaded, the replisome is formed. Bidirectional
replication proceeds, that is two replisomes originating from an origin of replication. This
basic structure is referred to as replicon (19). Apart from the basic replication machinery,
additional factors such as Fen1, DNA ligase are required in the maturation and sealing of
DNA strands (18). The replisome originating from different replicon will encounter each
other, once the replicons have been completely replicated. It is believed that this leads to
the unloading of replisome from the chromatin, possibly by collision of the two

3

Figure 1. Schematic model depicting activation of DNA synthesis in mammals (20).
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replisomes.
Regulation of DNA synthesis by CDKs and DDK in mammals
Progression into S phase requires the kinase activity of CDK. Its binding partner, a
cyclin, regulates CDK activity. CDK2 in complex with Cyclin E is important for G1 to S
phase transition and CDK2/Cyclin A complex is required for progression through S
phase. The phosphorylation of specific residues of Cyclin/CDK complex keeps it in
inactive state. This phosphorylation is removed by CDC25 family of phosphatases, which
results in the activation of the complex (21). CDC25A dephosphorylates threonine 14 and
tyrosine 15 within the ATP binding loop on CDK1 and CDK2. Thus DNA synthesis is
driven by CDK activity, which is highly regulated.

G1 to S phase transition
In mammals, G1 to S phase transition requires the activity of CDK2/Cyclin E and CDK4
/Cyclin D1. The CDK4/Cyclin D1 protein complexes are specifically required for Sphase specific transcriptonal program, while CDK2/Cyclin E is important for the
activation of pre-IC complex. Sld2 and Sld3 are phosphorylated by CDK2/Cyclin E
(14,15) complex and this event facilitates protein-protein interaction and the activation of
the Mcm2-7 complex. Low CDK activity is required during pre-RC assembly and G2
phase. A premature activation of CDK during pre-RC assembly can lead to inhibition of
origin licensing or re-replication in G2 phase (22). Most of the key players involved in
DNA replication and its regulation are conserved from yeasts to humans.
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Replication stress and checkpoint activation
Considering the importance of DNA replication in cell cycle, the progression of DNA
replication is very carefully monitored inside the cells. The stability of the genome
depends upon the precise operation of the DNA replication machinery and the DNA
replication checkpoint pathway.

Replication stress generated by hydroxyurea (HU)
HU, an inhibitor of ribonucleotide reductase (RNR), has been of clinical and scientific
interest for more than 100 years (23). Diverse biological activities, which include
antibacterial, antifungal, antitumor and anti-inflammatory effects, have been
characterized for HU (23,24). It has also been used to treat sickle cell anemia, leukemia
and other malignancies, psoriasis and thrombocythemia. One major reason that this
molecule has been well studied is because of its effect on its primary target, RNR (25).
RNR is required for furnishing the precursors of DNA synthesis by catalyzing the
reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates (26). In
eukaryotes, RNR is composed of two large and two small subunits that form a heterotetrameric enzyme. The larger subunits have both catalytic and allosteric sites and the
small subunit contains an oxo di-ferric iron center that aids in the formation of a
catalytically essential tyrosyl free radical (26). Because RNR is an essential enzyme
involved in the synthesis and repair of DNA, there has been extensive research to find
small molecule inhibitors of the enzyme that can be used to treat cancers. For example,
inhibitors have been developed involving the iron chelators that can inhibit the formation
of the oxo di-ferric iron center in the small subunit (27). Inhibitors of another class called
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radical scavengers have been developed as well, which have the ability to quench the
tyrosyl free radical of the small subunit (26). HU is an example of this class. It can
specifically inhibit RNR because overexpression or mutation of the small subunit of RNR
has been shown to confer increased resistance to HU (25).
HU treatment leads to dNTP depletion inside the cells thereby generating replication
stress, leading to the activation of ATR (ATM-and Rad3-related) mediated checkpoint
signaling pathway (28) in mammals. Activated ATR phosphorylates various substrates to
maintain genomic integrity.

Activation of the DNA replication checkpoint pathway in fission yeast S. pombe
The replication checkpoint pathway can be functionally separated into three conceptual
parts, sensors, mediators and effectors. (29-31). In S. pombe, the key component of the
DNA replication checkpoint pathway (Fig. 2) is the effector kinase Cds1 (CHK2 in
humans) (32-34). Some of the direct targets of Cds1, such as Mus81 (35), Rad60 (36) and
Wee1, are specialized for dealing with S phase perturbations (37). Once activated by the
sensor kinase Rad3 (ATR in humans), Cds1 mediates most of the protective responses
inside the cells. Although the activation mechanism of Cds1 (Fig. 3) is relatively clear
(33,38,39), the activation of Rad3 is poorly understood. Most of the in vitro studies in
other model organisms (40-43) suggest that dNTP depletion inside the cells leads to
transient uncoupling of the replicative helicase and polymerase at the perturbed forks
generating ss-DNA coated by RPA. Rad3 recognizes this RPA coated ss-DNA in
association with its cofactor Rad26 (ATRIP in humans). Another protein complex
comprising Rad9-Rad1-Hus1 or the “9-1-1” checkpoint clamp complex is loaded by its
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loader Rad17-Rfc2-5 complex onto the junctions of single to double stranded DNA in
close proximity to the Rad3-Rad26 complex (44,45). Once these complexes are loaded,
Rad3 is activated by a poorly understood mechanism. Activated Rad3 phosphorylates
Mrc1 (mediator of replication checkpoint) and Rad9 in the “9-1-1” complex.
Phosphorylated Rad9 can recruit other factors such as the replication initiation protein
Rad4 (Dpb11 in budding yeast, TopBP1 in humans) to the stalled forks. In S. cerevisiae
and metazoans, the recruited Dpb11 or TopBP1 has been shown to activate the sensor
kinase by the “ATR- activation domain” to enhance signaling activity of the checkpoint
pathway (42,43,46,47). However this result has not been rigorously tested in vivo. Recent
studies have shown that the kinase activity of Rad3/ Mec1 stays intact in Rad4/Dpb11
mutant lacking the “ATR activation domain” (48-50), suggesting that activation of the
sensor kinase in both yeasts may not require Rad4 or Dpb11 under replication stress.
Alternatively, redundant factors are required to activate the sensor kinase (51-53).

Protective cellular responses induced by activated checkpoint
Under the conditions of a replicative stress, the DNA replication checkpoint is absolutely
required for cell survival. Once activated, the pathway elicits a number of protective
cellular responses, which includes protecting the replisome proteins from disassembling
at the perturbed forks, increasing the production of deoxyribonucleotides by stimulating
the RNR (54-56). The activated checkpoint also suppresses the firing of late replication
origins (57,58) and delays mitosis by controlling the enzymatic activity of CDK (59,60),
thereby providing ample time for the cells to deal with the stress. All checkpoint
responses are well coordinated inside the cells to ensure that DNA synthesis can properly
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Figure 2: Schematic outline of the DNA replication checkpoint in S. pombe
Recent studies suggest that a common set of sensors is assembled at the stalled forks in
all eukaryotes for initiation of the checkpoint signaling. In S. pombe, the sensor kinase
Rad3 phosphorylates and activates the effector kinase Cds1 via the mediator Mrc1.
Activated Cds1 is responsible for most of the checkpoint functions by phosphorylating
various downstream targets. The main function of the checkpoint is believed to be the
stabilization of the stalled forks so that they do not undergo catastrophic collapse.
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Figure 3: Phosphorylation network for efficient activation of Cds1
The four Rad3-dependent phosphorylations (marked with letter P) occur in parallel. Rad3
phosphorylates Thr11 in Cds1 at a basal level in the absence of Mrc1, Rad9, or
phosphorylation of the two proteins. Phosphorylation of the SQ cluster and the TQ motifs
in Mrc1 and Thr412 in Rad9 can all facilitate the phosphorylation of Cds1-Thr11 by Rad3.
Although phosphorylation of Mrc1 TQ motifs recruits Cds1 for its phosphorylation at
Thr11 by Rad3, it remains unclear how phosphorylated Mrc1 SQ cluster and Rad9-Thr412
promote phosphorylation of Cds1-Thr11 (dashed arrows). Phosphorylation of Thr11 is
known to promote trans-autophosphorylation of Thr328 in the kinase domain of Cds1,
which directly activates the enzyme, leading to full activation of the replication
checkpoint pathway in S. pombe.
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resume once the stress subsides. Consistent with the importance of the pathway in
protecting the genome integrity and cell survival, the pathway is highly conserved from
yeast to humans and defects in the pathway predispose to cancer (61-63).

Cellular responses to various other stresses
Cells experience a variety of other stress conditions due to damage of the cellular
structures caused by both exogenous sources such as UV radiation and endogenous
sources such as reactive oxygen species (ROS) generated from mitochondrial electron
transport chain. As a result eukaryotes have evolved a variety of cellular stress responses
that protect the cells from these stress conditions such as the heat shock response and
oxidative stress response. Failure in the protective responses may result in cell death (64).
These cellular responses are summarized below.

Heat shock response
One of the well-characterized and main survival responses initiated by the cells is the
heat shock response. It is the response initiated by the cells as a result of elevation in
temperature (65). Heat shock generates protein damage that leads to misfolding of
proteins. The response aids in thermotolerance, refolding misfolded proteins and prevents
protein aggregation. The response results in higher resistance of cells to various stress
conditions such as elevated temperature, anticancer drugs and oxidative stress (66,67).
General transcription and translation occurring inside the cells is halted, however, the
transcription of genes required for protective response is enhanced. The cells specifically
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up regulate genes encoding heat shock factors (HSFs) (68) to protect the cells from stress.
If the cells cannot cope with the stress, they may follow the fate of death.

Cellular response to unfolded proteins
Most of the newly synthesized proteins undergo a variety of posttranslational
modifications in the endoplasmic reticulum (ER). Various stress conditions such as
calcium ion imbalance, glucose starvation, increase in temperature and inhibition of
glycosylation lead to accumulation of unfolded proteins and activation of the unfolded
protein stress response (69,70). The stress response pathway improves the protein loading
and folding capacity of endoplasmic reticulum is also enhanced, thereby helping the cells
to cope with the stress and preventing it from undergoing cell death.

DNA damage response
Exposure of cells to chemotherapeutic agents, irradiation or environmental genotoxic
agents such as UV or polycyclic hydrocarbons can generate DNA damage inside the
cells. Damage to the DNA template leads to the activation of DNA damage response
(DDR) pathway comprising ATR and ATM (Ataxia Telangiectasia Mutated) kinases.
Activated kinases phosphorylate various downstream targets (71), to promote the DNA
repair processes. However if the damage is difficult for the cell to repair, the signal is
transmitted to induce cell death by apoptosis (72). Apoptosis-like cell death has been
reported in both S. pombe and S. cerevisiae following DNA damage and replication
stress, similar to the scenario in metazoa (73).
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Oxidative stress response
Aerobically respiring organism generate ROS. Most of them are generated by leakage
from mitochondrial electron transport chain (74). ROS include superoxide anion (O2−),
hydrogen peroxide (H2O2) and hydroxyl radical (OH). Under normal conditions, there
exist a balance between pro-oxidant species and antioxidant defense system. Oxidative
stress occurs when there is disturbance in this balance. Although cells have both
enzymatic and non enzymatic defenses that deal with oxidative stress (74), imbalance can
result in cell death by either apoptosis or necrosis (75,76). Oxidative stress leading to cell
death by apoptosis has been shown in yeast (77).

Cell death mechanisms in eukaryotes
Eukaryotic cells are remarkable in that they respond to different stress conditions in a
variety of ways to promote their survival. The initial response of the cells is to protect
and recover from the stress. These responses such as DNA damage response and heat
shock response are conserved in evolution from lower organisms to mammals. However,
if the stress remains unresolved, the cells follow the fate of death. Various cell deaths
programs such as apoptosis, necrosis and autophagy are activated that eliminate these
damaged cells from the organisms. In unicellular organisms such as yeast, some of these
cell death pathways are also conserved (73).

Apoptosis
One of the best-characterized cell death mechanisms is apoptosis. It is highly conserved
throughout evolution (78). Cells exhibit a particular morphology during apoptosis. Cell
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blebbing, shrinkage, rounding and fragmentation of nuclei, margination of chromatin and
phagocytosis of cell fragments are all associated with apoptosis (79). Oxidative stress,
irradiation and chemotherapeutic agents can all trigger apoptosis. The key death effector
molecules in apoptosis are caspases (80). They belong to a family of cysteine proteases
that are synthesized in their inactive form and once activated can cleave a variety of
substrates in the cytoplasm, which eventually lead to the morphological changes
mentioned above. Caspases can be activated by a number of mechanisms inside the cells.
One mechanism includes the aggregation of death receptors of tumor necrosis factor
(TNF) or TNF-related apoptosis inducing ligand (TRAIL), resulting in recruitment of
Fas-associated death domain (FADD) and procaspase-8 leading to the formation of death
inducing signaling complex (DISC) (81). Other mechanism of caspase activation
involves the release of cytochrome c from the mitochondrial intermembrane space (82).

Necrosis
Necrosis is a mechanism of cell death characterized by loss of control of ionic balance
resulting in water uptake, swelling and cell lysis (83). Cell lysis results in the release of
components of the cell, thereby evoking an immune response leading to inflammation.
The key molecule leading to necrosis mediated cell death is the serine/threonine kinase
RIP1 (84,85). Reactive oxygen species (ROS) and calcium are also involved in mediating
necrosis (86). ROS (87) and calcium (88) drive necrosis and have been shown to
inactivate caspases and apoptotic machinery.

Autophagy
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Autophagy is an intracellular degradation system that delivers cytoplasmic constituents to
the lysosome. Sequestration of vesicles, degradation of cytoplasmic proteins and
organelles are all part of autophagy (89). The resulting double membrane structures are
called autophagosome. The key genes that regulate autophagosme formation are
autophagy related genes (atg), which were first identified in yeast (89). Autophagosome
degrades its contents by acidic lysosomal hydrolases (89). Stresses such as growth factor
deprivation, inhibition of proteasomal degradation, shortage of nutrients, intracellular
calcium accumulation and endoplasmic reticulum stress all leads to autophagy (90-92).

Necroptosis
A programed form of necrosis is referred to as necroptosis. It is a well-defined
mechanism to defend against viruses, allowing the cells to commit suicide in a caspase
independent fashion (93). It is specific cell death mechanism employed by vertebrates
only.

In summary, my dissertation defines a novel cell killing mechanism of HU involving
oxidative stress in S. pombe and the synergistic effect of HU and SMP in suppressing cell
growth of wild type S. pombe, S. cerevisiae and pathogenic fungus C. albicans.
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MATERIALS AND METHODS
Yeast strains and plasmids
Standard methods and genetic techniques were used for the yeast cell culture (94). The S.
pombe strains were usually cultured at 30°C in YES (0.5% yeast extract, 3% dextrose,
and supplements) or in the synthetic EMMS medium lacking the appropriate supplements
(94). Glycerol plates were made in YES (0.5% yeast extract, and supplements), in which
3% glycerol was used to replace 3% dextrose. Yeast strains, plasmids and PCR primers
used in this study are listed in Table 2, 3 and 4 respectively. All mutations and sequences
were confirmed by DNA sequencing (Retrogen, San Diego, CA). All yeast
transformations were carried out by electroporation (Gene Pulser II; Bio-Rad)

Identification of new HU sensitive mutants
Screening of the new HU sensitive mutants was carried out following a previously
described method (95). Briefly, the logarithmically growing wild type YJ374 strain was
harvested and suspended in 50 mM Tris-Maleate buffer, pH 6.0 and treated with 375
µg/ml methylnitrosoguanidine (MNNG) in the same buffer for 90 min at room
temperature. MNNG is a potent carcinogen that alkylates genomic DNA at O6 of guanine
and O4 of thymine, leading to transition mutations between GC and AT. To identify new
HU sensitive mutants, the mutagenized cells were spread on YE6S plates and incubated
at 30˚C. The colonies were replica plated onto YE6S or YE6S containing HU to identify
those that were sensitive to HU. The initially identified HU sensitive mutants were
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backcrossed three times to remove the by-stander mutations. The resulting mutants were
crossed and compared with known checkpoint mutants in order to identify novel HU
sensitive mutants.

Disruption of hem13+ gene in wild type diploid strain
Disruption of hem13+ gene was done by integrating ura4+ marker into a region between
NcoI [the blunt ends were generated using DNA polymerase I, Large (Klenow) fragment
(New England BioLabs) for NcoI site] and HincII sites in the open reading frame (196 bp
to 335 bp from the start codon) in an ura4-D18 diploid wild type YJ18 strain. The
resulting ura4+ diploid strain was generated. The gene-specific insertion of ura4+ marker
into the hem13+ gene was confirmed by colony PCRs using primers outside of the
integration sites.

Integration of Hem13 (T263I) mutation at the genomic locus
The Hem13 (T263I) mutation was integrated at the genomic locus using the
∆hem13::ura4+ diploid strain. The wild type and mutant hem13 gene were cloned on
pIRT-2U vector. Both plasmids containing wild type and mutant gene were cut with
BspEI and BglII. The resulting 1551 bp fragment was purified by agarose gel
electrophoresis. The purified fragment was transformed into ∆hem13::ura4+ diploid
strain. The cells were allowed to recover on YE6S plates for 24 h and replica plated on 5fluoroorotic acid (5-FOA) plates to select for ura- colonies. The resulting diploid uracolonies were allowed to sporulate on plates with poor medium. Random spore analysis
was performed to separate the spores.
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Drug sensitivity
To test the drug sensitivity by spot assay, 2 x 107 cells/ml of logarithmically growing S.
pombe were diluted in five-fold steps and spotted onto YE6S plates containing HU,
MMS, or CPT at indicated concentrations. The cells spotted on YE6S plates were also
treated with the indicated doses of UV light (Stratalinker 2400). The plates were
incubated at 30°C for 3 days and then photographed.

The sensitivity of hem13 cells to acute HU treatment was measured by using a previously
described method (95). Briefly, HU was added to the liquid culture in YE6S medium at
the final concentration of 25 mM. At each indicated time point, 10 µl of cells were
diluted in 10 ml sterile dH2O, vortexed and 100 µl of the cell suspension was then spread
onto YE6S plates. The plates were incubated at 30°C for 3 days for the cells to recover.
The number of the colonies resulting from the recovered cells were counted and
presented as percentages of the untreated cells. Each data point represents an average of
the colonies from three plates.
To test the sensitivity of S. pombe to H2O2, 30% w/w aqueous solution of H2O2 (Alfa
Aesar) was diluted to 3% (880 mM) solution in autoclaved water. Once the YE6S /agar
solution was cooled enough for pouring, H2O2 was added to the indicated concentrations
and the YE6S medium containing H2O2 was poured. The plates were kept in dark at 4˚C
before use.

To assess the cell killing effects of HU, SMP and their various combinations,
logarithmically growing S. pombe, S. cerevisiae and C. albicans cells were inoculated on
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96 well plates at 3000 cells/well. Various drugs and their combinations were added to the
final volume of 200 µl. The same amounts of carriers were added as the control. Cells
were incubated at 30˚ C for 48 h. The plates were scanned in a plate reader at A600. The
synergistic, additive, or antagonistic effect of the drug combinations, as indicated by the
combination index (CI) values for non-constant combo ratios, were calculated by using
the Chou and Talalay method (96,97).

TABLE 1. Combination Index values
The table showing the range of the CI values, which were used as reference to determine
synergism, additive and antagonism for the various drug combinations used.
Range of
Combination Index
<0.1
0.1-0.3
0.3-0.7
0.7-0.85
0.90-1.10
1.10-1.20
1.20-1.45
1.45-3.3
3.3-10
<10

Interpretation
Synergism (very strong)
Synergism (strong)
Synergism (moderate)
Synergism (slight)
Additive (nearly)
Antagonism (slight)
Antagonism (moderate)
Antagonism
Antagonism (strong)
Antagonism (very strong)

Drug combinations used for S. pombe (Fig. 36):
Conc. of HU used (mM): 0, 1.5, 5.0, 7.5, 10.0
Conc. of SMP used (mM): 0, 0.004, 0.012, 0.017, 0.021
Combo 1: (0+0), (1.5+0.004), (5.0+0.004), (7.5+0.004), (10.0+0.004)
Combo 2: (0+0), (1.5+0.012), (5.0+0.012), (7.5+0.012), (10.0+0.012)
Combo 3: (0+0), (1.5+0.017), (5.0+0.017), (7.5+0.017), (10.0+0.017)
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Combo 4: (0+0), (1.5+0.021), (5.0+0.021), (7.5+0.021), (10.0+0.021)
Drug combinations used for S. cerevisiae (Fig. 39):
Conc. of HU used (mM): 0, 100.0, 150.0, 200.0, 225.0, 250.0
Conc. of SMP used (mM): 0, 0.004, 0.008, 0.017, 0.025, 0.034
Combo 1: (0+0), (100.0+0.004), (100.0+0.008), (100.0+0.017), (100.0+0.025),
(100.0+0.034)
Combo 2: (0+0), (150.0+0.004), (150.0+0.008), (150.0+0.017), (150.0+0.025),
(150.0+0.034)
Combo 3: (0+0), (200.0+0.004), (200.0+0.008), (200.0+0.017.0), (200.0+0.025),
(200.0+0.034)
Combo 4: (0+0), (225.0+0.004), (225+0.008), (225.0+0.017.0), (225.0+0.025),
(225.0+0.034)
Combo 5: (0+0), (250.0+0.004), (250.0+0.008), (250.0+0.017.0), (250.0+0.025),
(250.0+0.034)
Drug combinations used for C. albicans (Fig. 42):
Conc. of HU used (mM): 0, 100.0, 150.0, 200
Conc. of SMP used (mM): 0, 0.064, 0.075, 0.086
Combo 1: (0+0), (100.0+0.064), (100.0+0.075), (100.0+0.086)
Combo 2: (0+0), (150.0+0.064), (150.0+0.075), (150.0+0.086)
Combo 3: (0+0), (200.0+0.064.0), (200.0+0.075), (200.0+0.086)

Sequence alignment
The protein sequence alignment was done using the following website:
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http://www.bioinformatics.org/sms2/pairwise_align_protein.html

Generation of anaerobiosis
Anaerobic environment was generated using Type A Bio-Bag Environmental Chamber
(Becton Dickinson, BD). To test the drug sensitivity under anaerobic conditions, serial
dilution of cells were spotted on YE6S alone or YE6S plates containing HU. Type A BioBag is a transparent, individual, disposable environmental chamber that contains a gas
generator consisting of one tablet of potassium borohydride and sodium bicarbonate, an
ampule of hydrochloric acid, a catalyst cup containing palladium catalyst, and an
indicator containing an ampule of resazurin. The plates and all the components
mentioned above were put in the Bio-Bag. After the bag was properly heat-sealed, the
generator was activated. The oxygen reduction indicator, resazurin, was used to monitor
the oxygen level as per manufacturer’s instructions.

Measuring protein carbonylation levels in S. pombe
Protein carbonylation was detected by in vitro derivatization of oxidized proteins with
2,4-dinitrophenylhydrazine (DNPH) (98,99). An overnight culture of yeast cells was
seeded into fresh medium at 0.1 OD600nm / ml (Optical Density) and incubated at 30˚C for
about 2 doubling times. The culture was split into 2 tubes, with one exposed to 25 mM
HU for 4 h and the other to water alone. Similar numbers of cells were harvested and
resuspended in carbonylation buffer (50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 0.05% NP40, 2 mM phenylmethylsulfonyl fluoride (PMSF), 5 mM benzamidine, 0.16 mg/ml
aprotinin) and lysed using the glass beads method. Cell lysates were centrifuged to
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eliminate debris. The protein concentration was then determined by Pierce BCA protein
assay kit (ThermoFisher Scientific). The protein concentration was adjusted to 10 mg/ml
with the carbonylation buffer. A concentrated 12% solution of sodium dodecyl sulfate
(SDS) was added to 10 µg of total protein to reach a final concentration of 6%, and
incubated for 3 min at 100˚C. One volume of 10 mM DNPH in 10% trifluoroacetic acid
was added to 1 volume of the sample. The reaction was run for 10 min at room
temperature and stopped by addition of 1 volume of 2 M Trizma base, 10 % glycerol and
15% 2-mercaptoethanol. Samples were separated by 10% SDS-polyacrylamide gel
electrophoresis (PAGE) and carbonylated proteins were detected using a polyclonal anti2,4-dinitrophenyl (DNP) antibody (Sigma). As a loading control, Protein Kinase G (Pkg)
was detected using rabbit polyclonal anti-Pkg2 antibody (Sigma). The immunoblotting
signal was revealed with electrochemiluminescence and photographed by Image Reader
LAS-3000 (Fuji Film). Intensities of the band were quantitated by ImageGauge (Fuji
Film). The protein carbonylation level in untreated wild type cells was set as 100%.

Western blotting
Phospho-specific antibodies against phosphorylated Mrc1-Thr645 and Cds1-Thr11 were
generated using the chemically synthesized phosphopeptides (33,38). Cds1 was tagged
with the hemagglutinin (HA) epitope at its C-terminus and immunoprecipitated (IPed)
from the whole cell lysates made by glass bead method from equal number of cells in the
buffer containing 50 mM HEPES/NaOH, pH7.6, 1 mM EDTA, 1 mM Na3VO4, 10 mM
pyrophosphate, 50 mM NaF, 60 mM β-glycerophosphate, 0.1% Nonidet P-40 and
protease inhibitors. After separation by SDS PAGE, the samples were transferred to a
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nitrocellulose membrane. The membrane was briefly probed with anti-HA antibody
(Santa Cruz Biotechnology) to confirm the IP and loading. The immunoblotting signal
was revealed with electrochemiluminescence and photographed by Image Reader LAS3000 (Fuji Film). The same blot was stripped and reprobed with the phospho-specific
antibody against Cds1-Thr11 for 3 h at room temperature or overnight at 4˚C.
Phosphorylation of Mrc1-Thr645 was directly examined in whole cell lysates prepared
from equal number of cells by trichloroacetic acid method (38). The membranes were
stripped and blotted with polyclonal antibodies against Mrc1 for loading. The Rad3
dependent phosphorylation of Chk1 was assessed using the mobility-shift method
developed by Russell lab (100).

Synchronization of cells in G1 phase
Cdc10 is the transcription factor required for the G1/S transition in S. pombe. Cells
containing the cdc10-129 temperature sensitive mutation were incubated in YE6S at
36.5˚C for 4 h. The G1 arrested cells were then released into the cell cycle at a semipermissive temperature of 30˚C, not 25˚C, because of the cold sensitivity associated with
hem13 mutant.

Flow cytometry
0.5 OD600nm/ml of logarithmically growing S. pombe cells were collected by
centrifugation and fixed in 1 ml of ice-cold 70% ethanol for 6 h or overnight at 4˚ C. The
fixed cells were treated with 0.1 mg/ml RNase A in 50 mM sodium citrate at 37˚ C for 6
h or overnight and then stained with 4 µg/ml propidium iodide (PI). The stained cells
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were run through Accuri C6 flow cytometer following standard protocol. The collected
data was analyzed using software FCS Express 4Flow. FL2-A channel was used for all
histograms.

Measuring heme levels in S. pombe
An overnight culture of S. pombe cells was seeded into fresh medium at 0.1 OD600nm / ml
and incubated at 30˚C for about 6 h. The culture was split into 3 tubes, with one exposed
to 25 mM HU for 4 h, one to 0.004 mM SMP for 4 h and the third one treated with
dimethyl sulfoxide (DMSO) alone as the control. We noted that at 0.004 mM
concentration, SMP minimally reduced the growth of wild type cells. Similar numbers of
cells from each culture were collected, washed once with ice-cold water, once with
phosphate buffer saline and then lysed. 2 µl of each cell lysate was used to measure the
amount of heme with a hemin assay kit (Bio Vision, CA) according to the manufacturer’s
instructions. The protein concentration of each cell lysate was also measured by Pierce
BCA protein assay kit (ThermoFisher Scientific) and used to calculate heme
concentration as fmol/µg protein. Three independent experiments were performed for
each culture and the results were averaged. The average heme level in the wild type strain
TK48 without the drug treatment was set as 100%.

Cloning S. cerevisiae hem13+ and human CPOX genes
Hem13 from budding yeast and CPOX from humans were cloned from budding yeast and
human cDNA library respectively and later expressed from S. pombe expression vector
under the control of nmt (no mRNA in the presence of thiamine) promoter.
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ROS staining assay
Logarthmically growing wild type and hem13 cells were treated for 3 h with 25 mM HU
at 30˚C. After 3 h of incubation in HU, the ROS indicator dye DCFDA (10 µg/ml) was
added and the cells were cultured for additional 90 minutes. Cells were then harvested
and washed twice with citrate buffer (50 mM sodium citrate, pH 7.0). The pellets were
resuspended in citrate buffer with or without PI (4 µg/ml) and then analyzed by flow
cytometry. The flow data was analyzed using software FCS Express 4Flow.

TABLE 2. List of S. pombe strains used in the study
Strain
YJ18

Genotype
h-/h+ leu1-32/leu1-32 ura4-D18/ ura4-D18 adeM210/ade-M216
TK48
h- leu1-32 ura4-D18 ade6-M216
NR1826 h- ∆rad3::ura4+ leu1-32 ura4-D18 ade6
GBY191 h+ ∆cds1::ura4+ leu1-32 ura4-D18 ade6-M210
YJ15
h+ ∆mrc1::ura4+ leu1-32 ura4-D18 ade6-M210
LLD3427 h- chk1-9myc-2HA6his::ura4+ leu1-32 ura4-D18
YJ374
h+ cds1-6his2HA(int) leu1-32 ura4-D18 ade6M216
TK197
h+ ∆chk1::ura4+ leu1-32 ura4-D18 ade6-M210
TK17
h- cdc10-129 ura4-D18 ade6-M210
APS18
h+/ h- ∆hem13::ura4+ leu1-32 ura4-D18 ade6
APS19
h?hem13(T263I) cds1-6his2HA leu1-32 ade6
APS34
h?∆hem13::ura4+ [prom-hem13-term LEU2]ura4D18 ade6
APS37
h?∆hem13::ura4+ [prom-hem13 (T263I)-term
LEU2]ura4-D18 ade6
APS70
h?∆hem13::ura4 leu1-hem13 ade6
APS71
h?∆hem13::ura4 leu1-hem13(T263I) ade6
APS124
h?hem13(T263I) cds1-6his2HA leu1-32 ura4-D18
ade6 (int.)
APS187
h?hem13(T263I) cds1-6his2HA [pREP1-H.S.
hem13-term] ura4-D18 ade6
APS188
h?hem13(T263I) cds1-6his2HA [pREP41-H.S.
hem13-term] ura4-D18 ade6
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Source
T. Kelly Lab
T. Kelly Lab
P. Russell lab
T. Kelly Lab
Y.J. Xu Lab
P. Russell lab
P. Russell lab
T. Kelly Lab
Y.J. Xu Lab
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study

APS189
APS190
APS169
APS170
APS181
APS183
PEY522
FG2341
YM526
YM563
APS162
APS185
APS123
APS121
APS122
APS97
APS99
APS184
APS171
YJ1259
YJ1230

h?hem13(T263I) cds1-6his2HA [pREP1-S.C.
hem13-term] ura4-D18 ade6
h?hem13(T263I) cds1-6his2HA [pREP41-S.C.
hem13-term] ura4-D18 ade6
h+ cds1-6his2HA(int) [prom-Suc22-term-LEU2]
leu1-32 ura4-D18 ade6
h+ ∆rad3::ura4+ [prom-Suc22-term-LEU2] leu1-32
ura4-D18 ade6
h+ ∆cds1::ura4+ [prom-Suc22-term-LEU2] leu1-32
ura4-D18 ade6
h? hem13(T263I) cds1-6his2HA [prom-Suc22-term
-LEU2] leu1-32 ura4-D18 ade6
h- ∆sre1::KanR leu1-32 ura4-D18 ade6-M210
his3-D1
h? ∆ptc4::ura4+ leu1-32 ura4-D18 ade6
h? ∆rad3::ura4+ chk1-9myc-2HA6his:ura4+ leu132
h? ∆cds1::ura4+ chk1-9myc-2HA6his:ura4+ leu132
h? cdc10-129 cds1-6his2HA(int) ura4-D18 ade6
h? cdc10-129 hem13(T263I) cds1-6his2HA(int)
ura4-D18 ade6
h? ∆rad3::ura4+ hem13(T263I) ura4-D18 ade6
h? ∆cds1::ura4+ hem13(T263I) ura4-D18 ade6
h? ∆chk1::ura4+ hem13(T263I) ura4-D18 ade6
h? hem13-HA:ura4+ leu1-32 ade6
h? hem13(T263I)-HA:ura4+ leu1-32 ade6
h+ ∆rad3::ura4+ [prom-Erg11-term-LEU2] leu132 ura4-D18 ade6
h? hem13(T263I) cds1-6his2HA [prom-Erg11term-LEU2] leu1-32 ura4-D18 ade6
h+ erg11(G189D):ura4+ cds1-6his2HA leu1-32
ura4-D18 ade6
h+ erg11(G189D):ura4+ cds1-6his2HA [promerg11-term-LEU2] leu1-32 ura4-D18 ade6

This Study
This Study
This Study
This Study
This Study
This Study
P. Espenshade
lab
P. Russell lab
Y.J. Xu Lab
Y.J. Xu Lab
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
Y.J. Xu Lab
Y.J. Xu Lab

TABLE 3. List of PCR and sequencing primers used in the study
Name
Hem13(P)SacI-f
Hem13(T)SphI-b

Sequence (5’ -> 3’)
AAAGGAGCTCTATTAGTTTATAACA
AAAG
GTACGCATGCTAACGTTTTATGACTT
G
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Note
Colony PCR
Gene cloning &
Colony PCR

Hem13(P)SacI-f
Hem13(444-463)f
Hem13(592-575)b
Hem13(239-222)b
Hem13(780-799)f
Hem13PSphI-f
Hem13 NotI-b
S.C.Hem13NdeI-f
S.C.Hem13SmaI-b
H.S.Hem13NdeI-f
H.S.Hem13SmaI-b
Ura4(term)f
Ura4-b2

TAGAGAGCTCATAGTAAAATACTTA
ACCATATG
CTTTGAAGAAGATGGCAAGC
GAAAATACCGCCAATGCCAC
TTTGGACAGCGTCTTGATTC
CAGAGGTACTTGGTTTGGTC
ACCCGCATGCGATCGCGCTATTC
GTGAGCGGCCGCAGCACCATTCAA
TAGGGG
CATACATATGCCTGCCCCTCAAG
GAACCCCGGGTTATTTAACCCACTC
CGGGCATATGGCCTTGCAGCTG
TCTGCCCGGGTCAACGCACCCAGTC
TTATAGATAAACACCTTGGG
CTACCAATTCTAAGATTTCGGATTT
C

Gene cloning
Sequencing
Sequencing
Sequencing
Sequencing
Tagging
Tagging
Gene cloning
Gene cloning
Gene cloning
Gene cloning
Colony PCR
Colony PCR

TABLE 4. List of plasmids used in the study
Name
pYJ1588
pAPS47
pAPS49
pAPS50
pAPS51
pAPS52
pAPS53
pAPS54
pAPS88
pAPS89
pAPS90
pAPS91
pYJ1519
pAPS66
pAPS67

Description
Prom-suc22+/LEU2
Prom-∆hem13 (ura4+)-term/ura4+
Prom-hem13+/ura4+
Prom-hem13 (T263I)/ura4+
Prom-hem13+-3HA/LEU2
Prom-hem13-3HA (T263I)/LEU2
Prom-hem13+/LEU2
Prom-hem13 (T263I)/LEU2
pREP1-S.C. hem13+-nmt term/LEU2
pREP41-S.C. hem13+-nmt term/LEU2
pREP1-H.S. hem13+-nmt term/LEU2
pREP41-H.S. hem13+-nmt term/LEU2
Prom-erg11+/LEU2
pJK148-Prom-hem13+
pJK148-Prom-hem13 (T263I)
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Source
Y.J. Xu Lab
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Y.J. Xu Lab
This study
This study

RESULTS
Identification of a novel hem13 mutant that is highly sensitive to HU in S. pombe
A novel HU sensitive mutant of coproporphyrinogen III oxidase in the heme biosynthesis
pathway
In order to better understand the activation mechanism of Rad3 in S. pombe, we designed
a genetic screening using low dose HU (2 mM). At this dose of HU, only the sensor
mutants of the checkpoint pathway (rad3∆, rad26∆, rad17∆, rad9∆, rad1∆ and hus1∆)
are sensitive, the mediator (mrc1∆), the effector (cds1∆), and the downstream factor
mutants survive (Fig. 2). We identified several mutants using low dose HU. To gate out
the known checkpoint mutants, we cloned all the genes in the checkpoint pathway on a S.
pombe expression vector. All vectors were stoichiometrically mixed as the defined
checkpoint library. The HU sensitive mutants that were identified using the above
mentioned genetic screening were transformed with the checkpoint library. The library
will rescue mutation in known checkpoint genes. With this strategy, we could quickly
gate out the mutations in known checkpoint genes and were able to identify several novel
mutants whose HU sensitivity was comparable to the checkpoint sensor mutants. Further
characterization of one of the novel mutant led to the identification of a new HU sensitive
mutant in the heme biosynthesis pathway (Fig. 4) with a mutation in hem13+ encoding
for the enzyme coproporphyrinogen III oxidase (101). In S. pombe, genome wide deletion
study identified hem13+ as an essential gene for cell growth (102). We confirmed this
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finding and showed that hem13+ is essential for cell survival (Fig. 6).
Coproporphyrinogen III oxidase is an oxygen requiring enzyme whose transcription is
regulated by cellular levels of oxygen and heme (103). It catalyzes the aerobic oxidative
decarboxylation of propionate groups of rings A and B of coproporphyrinogen-III to
yield the vinyl groups in protoporphyrinogen-IX (Fig. 4B) (104). Characterization of the
mutant identified a single nucleotide change resulting in T263I mutation in the catalytic
center of the enzyme. The HU sensitivity of hem13 mutant is remarkable in that it is even
higher than rad3∆ strain (Fig. 7A). The hem13 mutation was also associated with cold
sensitivity (Fig. 7B), whereby the mutant cells were unable to survive on plates incubated
at 22˚C, consistent with the essential function of the enzyme.
The homologous enzyme of Hem13 in humans is called coproporphyrinogen oxidase
(CPOX) (105). Defects in heme synthesis in humans leads to hepatic or erythropoietic
porphyrias. Acute hepatic porphyria, also called hereditary coproporphyria, is
characterized by acute attacks of neurological dysfunction (106-108). Skin
photosensitivity has also been predicted for the patients. Defects in erythropoietic cells
leads to harderoporphyria, which is characterized by neonatal hemolytic anemia and skin
lesions (109,110). The mutated amino acid threonine 263 in the hem13+ gene is believed
to be one of the catalytic residues in human homolog CPOX (104,111,112). Mutation of
the same residue to asparagine in humans reduced the enzymatic activity by 69% (105).

Confirmation of the mutation in hem13+ gene
The T263I mutation in hem13+ gene was confirmed in S. pombe. Wild type and mutant
genes were cloned on a S. pombe expression vector. The plasmid containing the wild type
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Figure 4: Schematic depicting heme biosynthetis pathway
A. The highly conserved enzymatic pathway starts with condensation of succinyl-CoA
and glycine and ends up with the formation of heme b, which is the major heme
molecule. While heme synthesis occurs partially in mitochondria, several intermediary
steps occur in cytoplasm. The hem13+ gene encodes the enzyme coproporphyrinogen
oxidase (shown in bold), involved in catalyzing the sixth step of the heme synthesis
pathway.

B. The enzyme catalyzes the aerobic oxidative decarboxylation of propionate groups of
rings A and B of coproporphyrinogen-III to yield vinyl groups in protoporphyrinogen-IX.
Short lines in the figure represent the propionate groups of rings A and B of
coproporphyrinogen III and vinyl groups of protoporphyrinogen IX.
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Figure 5: Disruption of hem13+ gene by integrating ura4+
The 934 bp open reading frame (ORF) of hem13+ and two flanking genes byr4+ and
SPAC222.17 are shown by long arrows. The hem13+ gene was cloned into the pIRT-2U
vector between SacI and SphI sites using PCR primers hem13(P)SacI-f and
hem13(T)SphI-b (short arrows). The 139 bp region of the hem13+ ORF (196 bp to 335 bp
from the start codon) between the NcoI (blunt end generated) and HincII sites was
replaced with ura4+ marker cut with BamHI (blunt end generated) and SmaI. The
resulting construct was digested with BglII and BspEI to isolate the 3885 bp fragment
containing the hem13+ destructed cassette by agarose gel electrophoresis. The purified
fragment was transformed into the wild type diploid strain YJ18. Colonies formed on
plates lacking uracil were screened by colony PCRs to confirm the 5’ and 3’ integration
using the indicated primer pairs generating 1300 bp and 2137 bp expected PCR products.
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Figure 6: Hem13 is essential for cell survival in S. pombe
A. The hem13+ gene was disrupted in diploid cells by integrating ura4+ gene into its
ORF. ura+ diploid colonies were selected and allowed to sporulate on plates with poor
medium. Tetrad dissection was performed to separate the spores. Out of colonies formed
from four spores, ≤ 2 colonies could survive suggesting that hem13+ is essential for cell
survival.
B. All the colonies formed above were ura- as the colonies failed to grow on ura- plates,
confirming that hem13+ gene is essential for cell survival.
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Figure 7: The newly screened hem13 mutant is highly sensitive to HU
A. Spot assay showing HU sensitivity of hem13 mutant. Wild type and rad3 mutant
strains were used as controls.
B. Cold sensitivity associated with the hem13 mutation. The mutant cells were unable to
grow on plates incubated at 22˚C as compared to wild type cells.
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Figure 8: Confirmation of hem13 mutation
A. Wild type or mutant Hem13 was expressed from plasmids under the control of its own
promoters in the hem13 mutant. Spot assay was done to monitor the HU and cold
sensitivity.
B. Wild type or mutant Hem13 was expressed in the hem13+/hem13∆ diploid strain from
plasmids. The diploid strain was allowed to sporulate to generate hem13∆ haploid cells
containing the plasmids. Spot assay was performed later.
C. The hem13 mutation was integrated at the hem13+ genomic locus in a wild type strain.
Wild type hem13+ was integrated by the same method. Standard spot assay was done to
show the HU and cold sensitivity of the integrated strains.
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Fig 9: Integration of Hem13 (T263I) mutation at the genomic locus
The Hem13 (T263I) mutation was integrated at the genomic locus using the hem13+
/∆hem13::ura4+diploid strain. The wild type and mutant hem13 gene were cloned on
pIRT-2U vector. Both plasmids containing wild type and mutant gene were cut with
BspEI and BglII. The resulting 1551 bp fragment was purified by agarose gel
electrophoresis. The purified fragment was transformed into ∆hem13::ura4+ diploid
strain. The cells were allowed to recover on YE6S plates for 24 h and replica plated on 5fluoroorotic acid (5-FOA) plates to select for ura- colonies. The resulting diploid uracolonies were allowed to sporulate on plates with poor medium. Random spore analysis
was performed to separate the spores.
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Figure 10: Partial rescue of hem13 mutant by S. cerevisiae and human orthologs
A. Pairwise sequence alignment of amino acid sequences of Hem13 protein in S. pombe,
S. cerevisae and human orthologs. Threonine 263, the mutated residue in hem13 mutant
is highly conserved from yeasts to humans.
B. Hem13 from budding yeast and CPOX from humans were expressed from S. pombe
expression vector under the control of nmt (no mRNA in the presence of thiamine)
promoter. The nmt1 and nmt41 indicates strong and weak promoters, respectively.
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gene could suppress the HU sensitivity of the mutant cells whereas the mutant version of
the gene failed to rescue, suggesting that the hem13 gene is mutated (Fig. 8A). The wild
type gene was also able to suppress the cold sensitivity of the mutant whereas the mutant
gene could not (Fig. 8A). Next we transformed the hem13+/hem13∆ diploid strain with
vectors expressing wild type and mutant hem13. Later the diploid colonies were allowed
to sporulate and haploid colonies with hem13∆ containing the plasmids were selected.
Plasmid carrying hem13+ gene could suppress both the HU and cold sensitivity in the
hem13∆ background in haploid cells whereas the mutant version of the gene expressed on
plasmid could not suppress the HU and the cold sensitivity (Fig. 8B). Finally the
mutation was integrated at the hem13+ genomic locus (Fig. 9) and HU and cold
sensitivity was confirmed (Fig. 8C).

C. Partial rescue of hem13 mutant by S. cerevisiae and human orthologs
Pairwise sequence alignment showed that mutated threonine 263 residue in Hem13 is
conserved among fission yeast, budding yeast and humans (Fig. 10A), and the mutated
residue is believed to be at the active site in human enzyme (104,111,112). It has been
reported that mutation of this residue to asparagine reduces the enzymatic activity of
CPOX by 69% (105). We cloned S. cerevisiae and human genes on S. pombe expression
vector and over-expressed in our hem13 mutant (Fig. 10B). Consistent with the conserved
function of the enzyme, the over-expressed S. cerevisiae and human orthologs can partly
rescue hem13 mutant. This result also suggests the possibility of decreased enzymatic
activity of hem13 mutant. It also suggests that a similar cell killing mechanism of HU
may be conserved from yeasts to humans.
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Checkpoint independent role of HU in sensitizing hem13 cells
Acute treatment of hem13 mutant with HU suggests a different cell killing kinetics in
hem13 mutant compared to the rad3∆ checkpoint mutant
The hem13 mutant is remarkably sensitive to chronic exposure of HU (Fig. 7). However
when we assessed the sensitivity of the hem13 mutant to acute HU treatment using
previously described method (95), we found hem13 mutant to be relatively insensitive
(Fig. 11). HU treatment of wild type cells slowed their growth but the cells were able to
survive indicating a reversible cell cycle arrest. On the contrary, by 3 h of HU treatment,
most of rad3∆ cells could not recover. However, the hem13 mutant was minimally
sensitive to acute HU treatment and was able to survive even after 6 h of HU treatment.
This result suggests that HU-induced cell death in hem13 mutant is caused by a different
mechanism.

Overexpression of Suc22 in hem13 mutant did not rescue its HU sensitivity
Another evidence that led us to suspect that a defect in checkpoint pathway may not be
the underlying cause of cell death in hem13 mutant came from the fact that when we
overexpressed Suc22 in hem13 mutant, we found that the HU sensitivity of the hem13
mutant could not be suppressed, in contrast to that in checkpoint mutants rad3∆ and
cds1∆ cells (Fig. 12). Suc22 is the small subunit of RNR and the major target of activated
replication checkpoint. As a result, overexpression of Suc22 can fully rescue the mutants
in the checkpoint signaling pathway. Thus this result also shows that cell death induced
48

Figure 11: The hem13 mutant is minimally sensitive to acute treatment of HU
Wild type, rad3∆ and hem13 cells were incubated in YE6S medium containing 25 mM
HU. At each time point, 10 µl of cells were diluted in 10 ml sterile dH2O, extensively
vortexed, and 100 µl or about 200 cells were then spread onto YE6S plates. The plates
were incubated at 30°C for 3 days for the cells to recover. Colonies resulting from the
recovered cells were counted and presented as percentages of the untreated cells. Each
data point represents an average of colonies from three plates.
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Figure 12: Overexpression of Suc22 in hem13 mutant did not rescue its HU
sensitivity
Unlike the rad3∆, cds1∆ checkpoint mutant cells, overexpression of the small subunit of
RNR Suc22 was unable to rescue hem13 mutant. Suc22 was expressed under the control
of its own promoter on a vector carrying the LEU2 marker. An empty vector was used as
a control. Spot assay was done to monitor HU sensitivity.
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by HU in the newly identified hem13 mutant is not due to dNTP depletion or DNA
damage generated by fork collapsing (113,114).

Resistance of hem13 mutant to DNA damaging agents
Next we monitored the sensitivity of hem13 mutant to DNA damaging agents MMS, CPT
and UV. We found that hem13 mutant is minimally sensitive to the DNA damaging
agents. In contrast, the checkpoint mutant rad3∆ is sensitive to these DNA damaging
agents under similar conditions (Fig. 13). Consistent with this result, we observed an
increase in Chk1 phosphorylation in hem13 mutant after treatment with MMS suggesting
that checkpoint signaling from Rad3 to Chk1 remained largely intact in hem13 mutant
after the cells were treated with MMS (Fig. 14A). The rad3∆ strain was used as negative
control in this experiment since Rad3 phosphorylates Chk1. Previous studies have shown
that Chk1 is also activated in HU treated cells lacking a functional replication checkpoint;
probably by DNA damage resulting from the collapsed forks (32). As a result, Chk1 is
highly phosphorylated in cds1∆ cells. If forks are collapsed in HU-treated hem13 mutant
cells, Chk1 should be phosphorylated. However, we found that Chk1 was minimally
phosphorylated in the presence of HU, suggesting that fork collapse occurs at a low level
in the hem13 mutant cells (Fig. 14B).

Phosphorylation of Cds1 in hem13 mutant cells
Cds1 is the major mediator of the replication checkpoint in S. pombe. Its activation
involves a two-stage mechanism (33,38,115): In the first stage, Cds1 is recruited by
phosphorylated Mrc1 for its phosphorylation by Rad3 at the Thr11 residue. In the second
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Figure 13: The hem13 mutant cells are minimally sensitive to DNA damage caused
by MMS, CPT or UV
The sensitivity of wild type, rad3∆, cds1∆, chk1∆ and hem13 cells to MMS (A), CPT (B)
and UV (C) was determined by spot assay.
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Figure 14: Chk1-mediated DNA damage response is not affected in hem13 mutant
Wild type, rad3∆, cds1∆ and hem13 cells were treated with (+) or without (-) 0.01 %
MMS (A) for 80 minutes or with 25 mM HU (B) for 4 h at 30˚C. The phosphorylation of
Chk1 by Rad3 was determined by standard mobility shift assay as described in Materials
and Methods.
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stage, phosphorylated Cds1 promotes homodimerization of two inactive Cds1 molecules,
which facilitates the autophosphorylation of Thr328 in the activation loop of the kinase
domain. Autophosphorylation of Thr328, which is suppressed by the autoinhibitory Cterminal tail, directly activates the Cds1 kinase. Because phosphorylation of Cds1-Thr11
by Rad3 primes the autoactivation of the kinase, it has been used as a reliable marker for
Cds1 activation (115,116). As shown in Fig. 15, phosphorylation of Cds1-Thr11 was
significantly increased in wild type cells after 3 h of HU treatment. However, we found a
dramatic reduction of Cds1 phosphorylation in hem13 mutant. This result showed that the
Rad3-mediated signaling in the replication checkpoint pathway was seriously
compromised in hem13 mutant, suggesting a defect in checkpoint pathway activation in
hem13 mutant, which is inconsistent with our results mentioned above that the cell death
is caused by checkpoint independent defect.
To understand why Cds1 phosphorylation was affected in hem13 mutant, we analyzed the
cell cycle progression of hem13 mutant. In the presence of HU, most of wild type cells
arrested in G1/S phase after 4 h of HU treatment. We found that hem13 mutant has a cell
cycle defect that might indirectly affect the Cds1 phosphorylation. While most of the wild
type cells arrested in G1/S phase after 4 h of HU treatment (Fig. 16), the hem13 cells
were unable to be arrested in G1/S phase by HU treatment. Surprisingly, most of the
hem13 cells remained in G2/M during the HU treatment suggesting a G2/M arrest (Fig.
16). Since Cds1 is specifically activated in S phase, a defect in cell cycle could be an
underlying cause of a defect in Cds1 activation. To investigate this possibility, we
crossed hem13 mutant with cdc10-129 temperature sensitive strain, selected for the
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Figure 15: Reduced Cds1 phosphorylation in hem13 mutant cells
Cds1 was tagged with HA epitope at the C-terminus and expressed at the cds1+ genomic
locus in wild type cells or the hem13 mutant. After the cells were treated with HU,
phosphorylation of Cds1-Thr11 was assessed in IPed Cds1 by Western blotting using
phospho-specific antibody (top panel). Loading of Cds1 was examined by blotting the
same membrane with anti-HA antibody (lower panel).

59

60

Figure 16: HU causes G2/M, not S phase arrest in hem13 mutant
The HU induced cell cycle arrest in wild type cells (left column) and in hem13 mutant
(right column) was analyzed by flow cytometry. The logarithmically growing
asynchronized cells were marked as “Asyn” on the bottom. Dashed lines indicate the 2C
DNA content.
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Figure 17: Forced entry of hem13 cells in S phase in the presence of HU restores
Cds1 phosphorylation
A. Logarithmically growing HA tagged Cds1 cdc10-129 (WT) cells or the HA tagged
Cds1 Cdc10-129 hem13 cells were arrested in G1 phase by incubating at the nonpermissive temperature (36.5˚C) for 4 h. The G1 arrested cells were then released into the
cell cycle by incubating at the semi-permissive temperature (30˚C) in the presence or
absence of HU (25 mM). Every hour during the release, an equal number of cells were
taken out from the culture to monitor Cds1 phosphorylation. Phosphorylation of Cds1Thr11 was assessed in IPed Cds1 by Western blotting using phospho-specific antibody
(top panel). Loading of Cds1 was examined by blotting the same membrane with anti-HA
antibody (lower panel).
B. The cells were also fixed at the indicated time points during the course of the
experiment for cell cycle analysis. The logarithmically growing asynchronized cells
before the G1 arrest were marked as “Asyn” on the bottom. Dashed lines indicate the 2C
DNA content.
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double mutant, and arrested the hem13 cdc10-129 double mutant cells at G1 phase of the
cell cycle by incubating at 36.5˚C and then released the cells at 30˚C (used 30˚C instead
of 25˚ C because of cold sensitivity of hem13 cells) in medium containing HU. During
the course of this block and release, Cds1 phosphorylation was monitored. We found that
Cds1 was fully phosphorylated in hem13 cells just like in the wild type cells under the
similar conditions (Fig. 17). Although, Cds1 was phosphorylated an hour before in
hem13 cells compared to wild type cells after release in HU, we believe that this is due to
cell cycle defect of hem13, leading to less stringent synchronization at G1 and
subsequently earlier release.

Reduced Mrc1 Phosphorylation levels in hem13 mutant
When DNA replication is perturbed by HU, Rad3 phosphorylates two TQ motifs in Mrc1
containing Thr645 and Thr653. Once phosphorylated, the two TQ motifs function
redundantly in recruiting Cds1 for its phosphorylation by Rad3 (38). As shown in Fig. 18,
when wild type cells were treated with HU, Mrc1-Thr645, which is used as the
representative of the two redundant TQ motifs, was highly phosphorylated and the
phosphorylation absolutely required Rad3. We found reduced Mrc1 phosphorylation in
hem13 mutant cells, suggesting a checkpoint defect. However, the Mrc1 levels were
lower in hem13 mutant compared to that in wild type cells. We believe that the lower
Mrc1 level is a result of cell cycle defect in hem13 cells, similar to the scenario leading to
reduced Cds1 phosphorylation in hem13 mutant cells because Mrc1 is specifically
expressed during S phase.
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Figure 18: Reduced Mrc1 phosphorylation in hem13 mutant cells
Wild type cells, cells lacking Mrc1 or Rad3 and hem13 mutant cells were incubated in
YE6S medium with (+) or without (-) HU (25mM) at 30˚C for 3 h. The cells were
collected for preparing the whole cell extracts as described in Materials and Methods.
After separation on SDS-PAGE, phosphorylation of Mrc1-Thr645 by Rad3 was examined
by Western blotting using the phospho-specific antibody (upper panel). Asterisk denotes
a cross-reactive material. The membrane was stripped and reprobed with the polyclonal
antibodies against Mrc1 (middle panel). A section of Ponceau S-stained membrane is
shown as loading control (bottom panel).
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Genetic interaction of hem13 mutant with checkpoint mutants
To see whether hem13 genetically interacts with the checkpoint mutants, we crossed the
hem13 mutation into rad3∆, chk1∆ and cds1∆ strains and tested the sensitivity of the
resulting double mutants to HU. We found that the double mutants were more sensitive to
HU than the single checkpoint mutant (Fig. 19). However the HU sensitivity of the
double mutants are similar to hem13 mutant suggesting that the hem13 mutation is
dominant.
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Figure 19: The hem13 mutant functions in a separate pathway with the checkpoint
mutants
The HU sensitivity of wild type, hem13 and the cells with the indicated single or double
mutations was determined by spot assay.
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Oxidative stress as an underlying cause of HU-induced cell death in hem13 mutant
Our data described above suggests that cell killing effect of HU in hem13 mutant is
independent of the checkpoint defect. Studies in other organisms (117-120) suggest that
in addition to DNA damage generated by collapsed forks, HU may kill the cells by
generating oxidative stress. SMP, an inhibitor of heme synthesis (121), has been shown to
induce apoptosis in a human leukemia cell line by generation of reactive oxygen species
(ROS) (122). We surmise that the cell death induced by HU in the newly identified
hem13 mutant could be due to increased ROS, not dNTP depletion (113,114).

Oxygen dependent HU and cold sensitivity of hem13 mutant
To test the hypothesis that HU-induced cell death in hem13 mutant is due to increased
ROS, we examined the HU sensitivity under anaerobic conditions since mitochondria are
the major intracellular source of ROS. We reasoned that if collapsed forks directly kill
the cells, the cell death should be observed in both checkpoint mutants and hem13 mutant
and the cell death should be independent of the two growth conditions. We observed that
while the checkpoint mutants remained sensitive to HU under anaerobic environment, the
sensitivity of hem13 mutant was fully suppressed under the similar conditions, suggesting
that HU sensitivity of hem13 is dependent on oxygen and that the cell death under
aerobic conditions may be due to increased ROS (Fig. 20A). Considering slower cell
growth rate and drug decomposition under anaerobic conditions, higher dose of HU was
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Figure 20: Oxygen dependent HU and cold sensitivity of hem13 mutant
A. Wild type, rad3∆, cds1∆, sre1∆ and hem13 were spotted on control and 5.0 mM HU
plates and incubated for 3 days at 30˚C under aerobic and anaerobic conditions. Sre1∆
mutant was used as the control for anaerobic conditions.
B. Wild type, rad3∆, cds1∆, sre1∆ and hem13 cells were spotted and incubated at 30˚C
and 22˚C under aerobic and anaerobic conditions for 3 days to monitor for the cold
sensitivity of hem13 mutant.
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used. It was found that the hem13 mutant cells were resistant to higher doses of HU under
oxygen restrictive environment. Sre1 is a sterol regulatory element binding protein, a
transcription factor required for cellular response to hypoxia (123). The sre1∆ mutant
was used as a positive control for anaerobic conditions because in the absence of Sre1,
the cells cannot survive under anaerobic conditions. We also monitored the cold
sensitivity of the hem13 mutant under oxygen restrictive environment and found that cold
sensitivity of hem13 can also be suppressed by depleting oxygen (Fig. 20B) because
heme is not required for cell growth under anaerobic conditions (124).

Sensitivity of hem13 mutant to other oxidants
The data described above suggest that HU may generate oxidative stress leading to cell
death in hem13 mutant cells. We then tested whether hem13 mutant is sensitive to
oxidants such as hydrogen peroxide (H2O2). We found that wild type and rad3∆ cells
were able to survive on plates containing 3 mM of H2O2, but not on plates containing 5
mM H2O2. However, hem13 mutant cells were sensitive to 3 mM H2O2, strengthening our
idea that oxidative stress is the underlying cause of cell death in HU-treated hem13
mutant cells (Fig. 21). Ptc4 is the protein phosphatase 2c required for activating the stress
induced MAP kinase Sty1 and is required during cellular response to H2O2 (125). The
ptc4∆ cells have been shown to be sensitive to H2O2 (125) and were used as positive
control in this experiment. As shown in Fig. 21, hem13 is even more sensitive to H2O2
than the ptc4∆ mutant under similar conditions.
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Figure 21: The hem13 mutant is hypersensitive to oxidative stress generated by
H2O2
Wild type, rad3∆, hem13 and ptc4∆ cells were spotted on control plates and plates
carrying varying concentration of H2O2 and incubated for 3 days at 30˚C. Ptc4 mutant is
required during cellular response to H2O2 and was used as a positive control for oxidative
stress.
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Next, we monitored hem13 cells survival on plates containing glycerol as the carbon
source instead of glucose. Yeast cells mainly undergo fermentation when glucose is
present in the medium to generate ethanol and carbon dioxide (126). Glycerol is a nonfermentable source of carbon. In the presence of glycerol, respiratory enzymes are
required to generate energy (126). Cells with increased oxidative stress will generate
more ROS in the presence of glycerol as the carbon source. The wild type and the
checkpoint mutant cells with intact enzymatic and nonenzymatic defenses required to
cope with oxidative stress were able to grow in the presence of the glycerol as the carbon
source. The ptc4∆ cells with a defect in oxidative stress response (125) were found to be
sensitive on plates containing glycerol and were used as the positive control. Under
similar conditions, the hem13 mutant cells were also found to be sensitive on plates
containing glycerol suggesting that hem13 mutant is sensitive to oxidative stress (Fig.
22). This sensitivity can be suppressed by adding glucose to the plates.

The HU sensitivity of hem13 can be suppressed by antioxidant N-acetylcysteine
We then examined the HU sensitivity of hem13 in the presence of the antioxidant Nacetylcysteine. An earlier study has shown that mutant cells with increased oxidative
stress survive better in the presence of antioxidant cysteine (126). We hypothesized that
the presence of antioxidant on the plates will prevent the oxidation of macromolecules
inside the cells, thereby helping the cells to survive better on HU plates. We observed
that the HU sensitivity of hem13 cells was suppressed by the antioxidant even at 5 mM
concentration (Fig. 23). cds1∆ cells survived slightly better at 3 mM HU concentration in
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Figure 22: The hem13 mutant sensitivity on plates containing glycerol as carbon
source
Wild type, rad3∆, hem13 and ptc4∆ cells were spotted on control plates and plates
carrying glucose, glycerol and glucose + glycerol as carbon source. The plates were
incubated for 3 days at 30˚C. The ptc4∆ strain was used as positive control because it is
sensitive to oxidative stress (125).
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Figure 23: Anti-oxidant can suppress the HU sensitivity of hem13 cells
The sensitivity of wild type, rad3∆, cds1∆ and hem13 cells to HU and HU + anti-oxidant
N-acetyl cysteine was determined by spot assay. After spotting the cells on plates, the
plates were incubated at 30˚C for 3 days.
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the presence of the antioxidant, probably because inappropriate entry into mitosis in
checkpoint mutants has been shown to generate ROS inside the cells (127). However at 5
mM HU, the cds1∆ cells did not show increased survival in the presence of the
antioxidant. The antioxidant did not show any effect on the HU sensitivity of rad3∆
mutant.

Increased production of ROS inside the hem13 mutant cells as measured by DCFDA
staining
The results described above strongly suggest that HU treatment generates oxidative stress
in hem13 mutant. However, direct evidence remains lacking. We used the cell membrane
permeable DCFDA dye to detect the generation of ROS (128). Thus it can detect ROS in
both living and dead cells. We used PI (129) to distinguish between dead and live cells;
since PI cannot pass through the intact membranes of living cells. Because fission yeast
cells display auto fluorescence even in the absence of dye, we measured the extent of
staining in the absence as well as the presence of dyes. We found that while the untreated
wild type cells show very insufficient fluorescence signal, the HU treated wild type cells
have slightly higher fluorescence signal in the presence of HU. The untreated hem13 cells
had slightly higher signal whereas the HU treated hem13 cells showed a significant
increase in the fluorescence signal suggesting increased ROS (Fig. 24). Although, in the
absence of dye, the hem13 cells alone showed a shift in the signal. This signal is different
than the fluorescent signal obtained from the DCFDA. Thus an increase in DCFDA
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Figure 24: Increased DCFDA fluorescence signal inside the HU treated hem13 cells
A. Wild type and hem13 cells treated with or without HU were incubated in the presence
of DCFDA for 80 minutes at 30˚C. The cells were then harvested, washed and
resuspended in buffer containing PI. The results are displayed as scatter plots with
increasing ROS displayed on horizontal axis and increasing PI signal displayed on the
vertical axis. In each case 10,000 cells were scanned. To count the DCFDA positively
stained cells, the gaits were set as shown in the figure. The gait boundaries were set up to
include the cells in the stained populations having fluorescence signals higher than those
in the unstained populations. The percentage of cells appearing in each of the gated
regions is also displayed.
B. The same results were displayed in histogram form with increasing amounts of ROS
on the horizontal axis.
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fluorescence signal inside hem13 cells as a result of HU treatment suggests increased
oxidative stress generation with HU treatment.

Increased protein carbonylation inside the hem13 mutant as a result of HU
treatment
We provided another evidence of increased oxidative stress inside hem13 cells treated
with HU by measuring protein carbonyaltion levels. Protein carbonylation is an
irreversible protein damage caused by oxidative stress which leads to the loss of protein
function (130). This type of protein damage has been considered as a reliable indicator of
oxidative damage (130). The side chains of lysine, arginine, proline, threonine and other
amino acid residues can be oxidized to ketones and aldehydes under oxidative stress.
These reactive ketones and aldehydes can react with DNPH to form hydrazone moieties
that can be detected using antibodies against DNPH derivatized proteins by western
blotting (98,99). We measured protein carbonylation in hem13 mutant cells treated with
or without HU and found that the protein carbonylation levels were significantly higher
in the HU-treated hem13 mutant cells indicating that HU increases oxidative stress inside
the hem13 cells (Fig. 25). The untreated hem13 mutant cells have slightly higher level of
protein carbonylation suggesting oxidative stress under normal growth conditions,
compared to untreated wild type and rad3∆ cells. This experiment provided one more
piece of direct evidence that there is significantly increased oxidative stress inside hem13
cells after HU treatment. The wild type and rad3∆ cells have minimal levels of protein
carbonylation, which further decreased slightly with HU treatment suggesting that
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activation of oxidative stress regulon remains intact inside these S. pombe cells similar to
the scenario in S. cerevisiae (120).

86

Figure 25: Increased protein carbonylation inside hem13 mutant cells
Wild type, rad3∆ and hem13 cells were treated with 25 mM HU for 4 h. Same number of
cells were collected, suspended in protein carbonylation buffer and lysed. Cell extracts
were reacted with DNPH, followed by SDS-PAGE and western blot analysis by using αDNP antibody. A section of the Ponceau S stained membrane and western blotting using
anti-PKG antibody were used as the loading controls.
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Heme deficiency predisposes cells to HU-induced oxidative stress
Reduced heme levels inside hem13 mutant
Since the Thr263 residue mutated in Hem13 has been proposed to be the active site residue
of the human CPOX and mutation of this residue to asparagine in humans reduces the
enzymatic activity by 69% (105), we surmised that the mutation causes heme deficiency
in hem13 mutant. To test this possibility, the heme levels inside the hem13 cells were
measured using the heme measuring kit (Bio Vision, CA). We measured the heme levels
inside the wild type and hem13 cells untreated or treated with 25 mM HU or 0.004 mM
SMP and found that heme levels were lower in hem13 cells compared to the wild type
cells (Fig. 26). HU treatment slightly reduced the heme levels inside the wild type cells
and hem13 mutant, possibly because of the requirement of heme for generating more
ergosterol inside the cell (discussed below), whereas SMP treatment dramatically reduced
the heme levels inside the cells as expected. We used 0.004 mM of SMP because at this
concentration, wild type cells were minimally sensitive to SMP. hem13 mutant cells did
not show any marked difference in heme levels with SMP treatment probably because
heme was already at the lowest level inside the mutant cells. Thus this experiment
provides direct evidence that heme level is low in hem13 mutant cells.

Exogenously supplied hemin can suppress HU and cold sensitivity of hem13 mutant
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Figure 26: Reduced heme levels inside the hem13 mutant cells
Wild type and hem13 cells treated with 25 mM HU or 0.004 mM SMP were lyzed. Cell
extracts were used to measure the heme levels using heme measuring kit. The protein
concentration of each cell lysate was also measured and used to calculate heme
concentration as fmol/µg protein. Bar: Standard deviation. *: Statistically significant with
p-values < 0.05.
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Figure 27: Exogenously supplied hemin can suppress both HU and cold sensitivity
of hem13 mutant cells
A. Wild type, rad3∆ and hem13 mutant cells untreated (-) and treated (+) with 50 µg/ml
of hemin for three days were spotted on control, HU, hemin (50 µg/ml) and HU + hemin
plates and incubated further for 3 days at 30˚C.
B. Similar to A, cells were cultured with 50 µg/ml of hemin for three days and were
spotted on control and hemin (50 µg/ml) plates and incubated at 22˚C for 3 days to
monitor for cold sensitivity.
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Since heme level was low inside the hem13 mutant, we wanted to test if exogenously
supplied hemin can suppress the HU and cold sensitivity. We treated the wild type, rad3∆
and hem13 cells with exogenous hemin for three days and then spotted the cells on HU
and HU + hemin plates. We found that the exogenously supplied hemin can suppress
both HU and cold sensitivity of hem13 mutant cells (Fig. 27 A, B). Even at 5 mM HU
concentrations, the cells were able to survive just like the wild type cells. In contrast, the
exogenously supplied hemin could not suppress the HU sensitivity of rad3∆ strain. This
result suggests that reduced heme inside the hem13 cells is the underlying cause of both
HU and cold sensitivity of hem13 cells.

Increased Hem13 protein levels inside the hem13 mutant cells
An earlier study showed that Hem13 is an oxygen-requiring enzyme and is negatively
regulated by heme and oxygen levels inside the cells (103). We monitored the Hem13
levels inside the hem13 cells and found that there was an increase in Hem13 protein level
compared to the wild type cells (Fig. 28), consistent with the notion of reduced heme
levels inside the hem13 mutant cells. However, HU treatment did not further increase the
Hem13 protein levels inside the wild type and hem13 cells. Thus the increased Hem13
levels inside the hem13 mutant are consistent with reduced heme levels inside the hem13
cells in the presence or absence of HU.

Exogenously supplied hemin can alleviate the cell cycle defect of hem13 mutant
Cell cycle analysis by flow cytometry showed a cell cycle defect in hem13 mutant (Fig.
16), in which the mutant cells arrested in G2/M phase, not G1/S by HU. Since
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Figure 28: Increased Hem13 protein levels inside the hem13 cells
Untagged, HA-tagged Hem13 expressed in wild type and hem13 mutant cells were
treated with or without HU and the cells were collected and lysed. Whole cell extracts
were prepared, run on SDS page gels, transferred on to the nitrocellulose membrane and
probed with anti-HA antibody (Top panel). A section of the Ponceau S stained membrane
is shown as the loading control (bottom panel).
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Figure 29: Cell cycle defect of hem13 can be suppressed by exogenously supplied
hemin
Hem13 cells were incubated with (left panel) or without (right panel) 50 µg/ml hemin for
three days. The cells were then treated with 25 mM HU. The cells were fixed at the
indicated time points during the course of the experiment for cell cycle analysis by flow
cytometer. Dashed lines indicate the 2C DNA content. Asynchronized cells at the bottom
represent the cells at the start of the HU treatment.
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exogenous hemin can suppress HU sensitivity, we tested if exogenously supplied hemin
can also correct the cell cycle defect. We found that in the presence of exogenously
supplied hemin, nearly half of the cells arrested in G1/S phase, in contrast to the
untreated cells, which remained in G2/M phase in the presence of HU (Fig. 29).

Excess of free iron inside the cells- an underlying cause of HU sensitivity
The results described above showed that the mutation in Hem13 causes the deficiency of
heme. However, why the heme deficiency sensitizes the cells to HU remains unknown. In
yeasts, majority of the iron taken by the cells is utilized for the synthesis of heme and
assembly of the iron-sulfur clusters, which occurs in the mitochondria (131). The
deficiency of heme inside the hem13 cells may lead to excess labile iron inside the
mutant cells. Since free iron can promote the formation of free radicals inside the cells
(132), it is possible that excess free iron might be involved in generating oxidative stress
inside the cells and causes the HU sensitivity. To test this idea we used the membrane
permeable, intracellular Fe2+ chelator, 2,2’-bipryidine (BP) which has been shown
previously to quench the labile iron pool within the eukaryotic cells (133-135). We
hypothesized that chelating this labile iron pool, which may otherwise promote
generation of free hydroxyl radicals inside the cells, will help the hem13 cells to survive
better. We found that wild type cells showed slight suppression of cell growth when both
HU and BP were present in the plates. The situation is worst for cds1∆ checkpoint mutant
because adding HU and BP together completely suppresses its growth, probably by
quenching the iron required for RNR recycling (26). However, the hem13 mutant cells
survive better on HU plates in the presence of BP, suggesting that an excess of free iron

99

could be one of the underlying causes of HU sensitivity in hem13 mutant cells (Fig.
30A).

Overexpression of Hem15 suppresses HU sensitivity of hem13 cells
hem15+ in S. pombe encodes for ferrochelatase. In S. cerevisiae, ferrochelatase is an inner
mitochondrial membrane protein (136) that catalyzes the last step of the heme
biosynthetic pathway (Fig. 4A) by inserting ferrous iron into protoporphyrin IX (137).
We found that overexpression of Hem15 in hem13 mutant partially suppresses its HU
sensitivity possibly by binding of free labile iron (Fig. 30B). Alternatively, more end
product heme is synthesized in the cells.
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Figure 30: Quenching free iron inside the cells suppresses HU sensitivity of the
hem13 mutant
A. Wild type, rad3∆, cds1∆ and hem13 cells were spotted on control plates, HU and HU
+ bipyridyl plates. The plates were incubated further for 3 days at 30˚C.
B. Hem15 was overexpressed under the control of its own promoter on a S. pombe
expression vector. An empty vector was used as control. Serial dilutions of wild type and
hem13 mutant carrying empty vector and hem15+ were spotted on control and HU plates.
The plates were incubated further for 3 days at 30˚C.
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Partial rescue of HU sensitivity of hem13 mutant by overexpression of Erg11
Since overexpression of the small subunit of RNR Suc22 could not suppress the HU
sensitivity of hem13 mutant cells, suggesting that in addition to RNR, there may be a
secondary target of HU. Identification of such a target(s) can be of great biological and
clinical significance. To look for the potential new target of HU, we screened for multiple
copy suppressors of hem13 mutant. To this end, we transformed the hem13 mutant with
the genomic DNA libraries established in our lab that carry the ura4+ marker. Colonies
grown on plates lacking uracil were replicated on plates containing HU to screen for
those that are endowed with HU resistance. Plasmids were recovered from HU resistant
yeast colonies for DNA sequencing and subsequent identification of the suppressor
genes. Interestingly, we found that erg11+ could suppress the HU sensitivity of the
hem13 mutant (Fig. 31). In S. cerevisiae, erg11+ encodes for lanosterol 14-demethylase, a
member of cytochrome P-450 family, in the biosynthesis of ergosterol, a sterol similar to
mammalian cholesterol that is specifically found in fungal membranes (138). Data from
budding yeast suggests that Dap1, a heme binding protein, activates Erg11, thereby
elevating the metabolism of lipids and xenobiotic compounds and provides resistance to
DNA alkylating agent methyl methanesulfonate (MMS) (139). It is possible that proper
functioning of Erg11 is affected in hem13 mutant due to heme deficiency and decreased
ergosterol synthesis may also cause the HU sensitivity. Consistent with this notion, a
newly identified erg11 mutant in our lab is highly sensitive to HU (Fig. 31). We further
tested the hem13 mutant sensitivity to ergosterol inhibitor terbinafine and found that
hem13 mutant is more sensitive to this agent suggesting that ergosterol synthesis may be
affected in hem13 mutant (Fig. 32).
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Figure 31: Overexpression of Erg11 can partially suppress the HU sensitivity of
hem13 mutant
Erg11 was expressed in wild type, rad3∆, erg11 and hem13 mutant under the control of
its own promoter. Serial dilutions of above mentioned cells were spotted on control plates
and plates containing different concentrations of HU. The plates were incubated further
for 3 days at 30˚C. One of the plates was incubated at 22˚C for 3 days to monitor for cold
sensitivity. Cells transformed with empty vectors were used as controls.
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Figure 32: The hem13 mutant is more sensitive to ergosterol inhibitor terbinafine
Wild type, rad3∆, cds1∆, chk1∆, erg11 and hem13 cells were spotted on control plates
and plates containing different concentrations of terbinafine. Unlike the checkpoint
mutants that have similar sensitivity as the wild type cells, the hem13 mutant was more
sensitive to terbinafine.
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Synergistic effect of HU and SMP in suppressing fungal cell growth
The hem13 mutant is highly sensitive to an inhibitor of heme synthesis, SMP.
Since HU sensitivity of hem13 mutant is attributed to low heme levels inside the cells; we
hypothesized that hem13 mutant with a defect in heme synthesis would be more sensitive
to SMP and WT, rad3∆ and cds1∆ cells with intact heme synthesis pathway will be
relatively resistant to SMP. We found that the wild type and checkpoint mutant cells
rad3∆, cds1∆, were much less sensitive to SMP, in contrast to hem13 mutant that is
highly sensitive to SMP (Fig. 33).

Synergistic effect of HU and SMP in suppressing the cell growth of S. pombe
Since the hem13 mutant is sensitive to the inhibitor of heme synthesis, SMP, we reasoned
that inhibition of the heme synthesis pathway in wild type S. pombe might mimic the
mutant phenotype and thus sensitize the cells to HU. To test this idea we performed a
spot assay on plates containing SMP, HU or both and monitored the drug effects on cell
growth. We used low concentration of HU (1.5, 3 mM) and SMP (0.004 mM). At these
concentrations of HU and SMP, wild type cells were able to survive on the plates.
However when these two drugs were combined together, there was a marked suppression
in cell growth suggesting a synergistic effect of the drugs on cell growth in wild type
cells (Fig. 34).
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Figure 33: The hem13 mutant is highly sensitive to an inhibitor of heme synthesis,
SMP
Wild type, rad3∆, cds1∆ and hem13 cells were spotted on control plates and plates
containing different concentration of SMP.

109

110

Figure 34: Increased sensitivity of wild type S. pombe cells to HU in the presence of
SMP
Wild type, rad3∆, cds1∆ and hem13 cells were spotted on control, HU, SMP and HU +
SMP plates.
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Figure 35: Cell killing effect of HU and SMP on wild type S. pombe
Logarithmically growing wild type S. pombe cells were inoculated on 96 well plates at
3000 cells/well. Various concentrations of HU (A) or SMP (B) were added to the final
volume of 200 µl to each well. The same amounts of carriers were added as control. Cells
were incubated at 30˚C for 48 h. The plates were scanned in a plate reader at A600. The
graphs were made from values obtained from the plate reader using Microsoft Excel.
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Figure 36: Combination of HU and SMP shows synergistic cell killing effect on wild
type S. pombe
A. CI values of the various drug combinations using non-constant combo ratios. Values
marked in bold indicate strong synergistic effects.
B. Graphical representation of the cell killing effect of HU, SMP and various
combinations of the two drugs. The numbers indicate the various combinations.
C. Combination index plot. Fa values on the x-axis are the values of cell survival at
various CI values.
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Figure 37: Time course analysis of a HU + SMP combo showing strong synergism in
wild type S. pombe
Logarithmically growing S. pombe cells were inoculated on 96 well plates at 3000
cells/well. The HU (10mM), SMP (0.021 mM) and their combo showing strong
synergistic effects were chosen for the time course analysis. The same amounts of
carriers were added as control. Cells were incubated at 30˚C and the plates were scanned
in a plate reader at A600 at the indicated time points. The graphs were then made from
values obtained from the plate reader using Microsoft Excel. Each data points are the
average of three readings.

117

118

To analyze this synergistic drug effect in detail, we measured the drug effects in 96 well
plates as described in Material and Methods. The dose response of each drug was
obtained in order to determine the concentration required to suppress 50% cell growth
(IC 50 value) (Fig. 35). The drug concentrations showing minimal effects on cell growth
were then chosen for the drug combinations. The synergistic, additive and antagonistic
effects between the combined drugs were determined by using Chou and Talalay method
(96). As shown in Fig. 36, most of the combinations of SMP and HU showed synergistic
effect as the calculated combination index (CI) values are less than 1.0 (see Table 1 in
Materials and Methods for detail) (97). Although a few combinations showed the additive
(CI values ≈ 1.0) or antagonistic (CI values > 1.0) effect, more than half of the
combinations showed a very strong synergism (CI values < 0.1) (Fig. 36, numbers in
bold). These data are consistent with the spot assay results from Fig. 34 and support the
result that the lower level of heme is the underlying cause of the hem13 mutant HU
sensitivity. We also monitored the cell killing effect by time course analysis of a HU +
SMP combo that showed strong synergism over the course of long term drug treatment
and found that after 16 h of HU and SMP treatment alone, the cells were able to recover
from the individual drugs whereas they failed to recover from the two drugs combined.

Synergistic effect of HU and SMP in suppressing the cell growth of S. cerevisiae
We also assessed the effect of SMP and HU on S. cerevisiae, another nonpathogenic
fungus that is phylogenetically distinct from S. pombe. The dose response of individual
drug was obtained to determine IC 50 value (Fig. 38). Similar synergistic effects were
observed in S. cerevisiae as described for S. pombe (Fig. 39).
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Synergistic effect of HU and SMP in suppressing the cell growth of C. albicans
We then tested the effect of HU and SMP on the pathogenic fungus C. albicans (Fig. 42).
Most of the combinations showed a strong synergistic effect. Similar to S. cerevisiae,
higher concentrations of HU are required to achieve the dramatic cell killing effect on C.
albicans as it is known that both fungi are more resistant to HU (Fig. 38A, 41A).
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Figure 38: Cell killing effect of HU and SMP on wild type S. cerevisiae
Logarithmically growing S. cerevisiae cells were inoculated on 96 well plates at 3000
cells/well. Various concentrations of drug alone were then added to the final volume of
200 µl to each well. The same amounts of carriers were added as control. Cells were
incubated at 30˚C for 48 hrs. The plates were scanned in a plate reader at A600. The
graphs were then made using excel from values obtained from the plate reader.
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Figure 39: Combination of HU and SMP shows synergistic cell killing effect on wild
type S. cerevisiae
A. CI values of the various drug combinations using non-constant combo ratios. Values
marked in bold indicate strong synergistic effects.
B. Graphical representation of the cell killing effect of HU, SMP and various
combinations of the two drugs. The numbers indicate the various combinations.
C. Combination index plot. Fa values on the x-axis are the values of cell survival at
various CI values.
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Figure 40: Time course analysis of a HU + SMP combo showing strong synergism in
wild type S. cerevisiae
Logarithmically growing S. cerevisiae cells were inoculated on 96 well plates at 3000
cells/well. The HU (250 mM), SMP (0.035 mM) and their combo showing strong
synergistic effects were chosen for the time course analysis. The same amounts of
carriers were added as control. Cells were incubated at 30˚C and the plates were scanned
in a plate reader at A600 at the indicated time points. The graphs were then made using
excel from values obtained from plate reader. Each data points are the averages of three
readings.
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Figure 41: Cell killing effect of HU and SMP on pathogenic fungus C. albicans
Logarithmically growing C. albicans cells were inoculated on 96 well plates at 3000
cells/well. Various concentrations of SMP were then added to the final volume of
200 µl to each well. The same amounts of carriers were added as control. Cells were
incubated at 30˚C for 48 hrs. The plates were scanned in a plate reader at A600. The
graphs were then made using excel from values obtained from the plate reader.
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Figure 42: Combination of HU and SMP shows synergistic cell killing effect on
pathogenic fungus C. albicans
A. CI values of the various drug combinations using non-constant combo ratios. Values
marked in bold indicate strong synergistic effects.
B. Graphical representation of the cell killing effect of HU, SMP and various
combinations of the two drugs. The numbers indicate the various combinations.
C. Combination index plot. Fa values on the x-axis are the values of cell survival at
various CI values.
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Figure 43: Time course analysis of a HU + SMP combo showing strong synergism in
pathogenic fungus C. albicans
Logarithmically growing C. albicans cells were inoculated on 96 well plates at 3000
cells/well. The HU (200 mM), SMP (0.086 mM) and their combo showing strong
synergistic effects were chosen for the time course analysis. The same amounts of
carriers were added as control. Cells were incubated at 30˚C and the plates were scanned
in a plate reader at A600 at the indicated time points. The graphs were then made using
excel from values obtained from the plate reader.
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DISCUSSION
Aerobically respiring organisms generate ROS, such as superoxide radicals, hydroxyl
radicals, hydrogen peroxide, which can damage various macromolecular components
inside the cells such as nucleic acids, proteins and lipids (140). One of the major sources
of oxidative stress in the aerobically respiring organisms is the mitochondrial electron
transport chain (ETC) (74). Cells have developed sophisticated mechanisms to deal with
ROS generated by aerobic respiration. These include enzymatic and nonenzymatic
defenses to maintain a reducing environment inside the cells. Glutathione, glutaredoxins,
thioredoxins and NADPH constitute the nonenzymatic defenses employed by the cells to
detoxify ROS (74). Superoxide dismutases, catalases and peroxidases constitute the
enzymatic defenses of the cells to detoxify ROS (141).
Recently, numerous studies suggest that HU, a RNR inhibitor (25) may generate
oxidative stress inside both prokaryotic (117) and eukaryotic cells (118,120) which
eventually lead to cell death. One of these studies suggests that HU sensitivity may not be
mediated through dNTP regulatory network (118). It is also known that HU can directly
kill cells by DNA damage resulting from collapsed forks as a result of dNTP depletion
inside the cells (113,114). These two cell killing mechanisms overlap since inappropriate
entry into mitosis in checkpoint mutant cells can generate ROS (76). A mutant that can
separate these two cell killing mechanisms of HU can be valuable. Our characterization
of the hem13 mutant provides several lines of evidences that HU generates oxidative
stress, not checkpoint defect leading to cell death (113,114).
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I provided the following evidence that cell death in hem13 mutant is independent of a
checkpoint defect. First, the failure of overexpressed Suc22 to rescue the HU sensitivity
of hem13 mutant (Fig.12) suggests that the defect is not mediated by dNTP regulatory
network. Second, the acute treatment of hem13 with HU shows a different kinetics of cell
death compared to the checkpoint mutant rad3∆ (Fig. 11). Third, resistance of hem13
mutant to other DNA damaging agents such as MMS, CPT and UV (Fig. 13) and an
intact Rad3 to Chk1 signaling (Fig. 14A) and minimal phosphorylation of Chk1 with HU
treatment (Fig. 14B) further supports the idea that cell death is not mediated by DNA
damage caused by collapsed forks. Although the dramatic reduction in Cds1
phosphorylation (Fig. 15) was inconsistent with our idea of checkpoint independent cell
death mechanism in hem13 mutant, it was found that defect in Cds1 phosphorylation was
a result of cell cycle defect in hem13 cells (Fig. 16) and Cds1 phosphorylation could be
fully restored in hem13 mutant cells by forcing the cells into G1 phase and then release in
S phase in the presence of HU (Fig. 17).
Next I provided evidence suggesting oxidative stress as an underlying cause of cell death.
First the HU sensitivity of hem13 mutant is dependent on oxygen (Fig. 20). I also found
that hem13 mutant is sensitive to other oxidants such as H2O2 (Fig. 21). Second, the HU
sensitivity of hem13 mutant could be suppressed by the presence of antioxidant N-acetyl
cysteine (Fig. 23), suggesting a strong correlation between oxidative stress and cell death.
Third, increased ROS staining by DCFDA (Fig. 24) and increased protein carbonylation
(Fig. 25) in HU-treated hem13 cells provided direct evidence of increased oxidative stress
in hem13 mutant as a result of HU treatment. Thus, my work unveils a novel cell killing
mechanism of HU in S. pombe.
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The key question is how this oxidative stress is generated inside the hem13 cells as a
result of HU treatment. My data suggest that hem13 mutant has reduced heme levels
inside the cells and this conclusion is supported by, first, heme measurements using a
commercially availaible kit showed that heme level is significantly lower in hem13
mutant cells (Fig. 26). Second, exogenously supplied hemin could suppress the HU and
cold sensitivity of hem13 mutant (Fig. 27) and also alleviate the cell cycle defect of
hem13 mutant (Fig. 29). Third, increased Hem13 protein levels inside the hem13 mutant
(Fig. 28) cells also suggest decreased levels of heme. Since exogenous hemin can fully
suppress the HU sensitivity, I believe that the heme deficiency predisposes the cells to
oxidative stress induced by HU in hem13 mutant. However the exact mechanism remains
unclear, which is discussed below.
The low heme levels inside the mutant cells may lead to an excess of free labile iron
inside the cells since most of the iron taken up by yeast is utilized for the synthesis of
heme and assembly of iron-sulfur clusters in the mitochondria (131). My hypothesis of
excess free iron inside the cells as a result of heme depletion is supported by the fact that
patients with mutation in CPOX, which is one of the underlying causes of human
coproporphyrias, have severe iron load (105). Some of the patients with mutation in
CPOX have very high serum ferritin levels (109). Since free iron is a powerful promoter
of free-radical damage, causing formation of hydroxyl radicals inside the cells (132), it is
possible that the increased free iron inside the hem13 cells causes oxidative stress. This
was indeed true as quenching the free iron inside the mutant cells with the membrane
permeant, intracellular Fe2+ chelator, 2,2’-bipyridine was able to suppress the HU
sensitivity of hem13 mutant (Fig. 30A). Overexpression of Hem15 encoding
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ferrochelatase, which binds iron inside the cells, also partially suppressed HU sensitivity
of hem13 mutant (Fig. 30B). Thus, my data suggests that there is excess free labile iron
inside the cells that may be one of the underlying causes of HU sensitivity of hem13
mutant. Alternatively, since heme is also required for respiratory enzymes, heme
deficiency may perturb their function leading to increased oxidative stress.
How excess free iron and HU treatment of the cells lead to oxidative stress? It has been
suggested that HU inhibition of RNR could result in the formation of the hydroperoxy
form of the HU, which can diffuse away from RNR and act as an oxidizing agent (26).
The oxidized form of HU generates more oxidative stress in hem13 mutant compared to
the wild type cells, possibly by reacting with the increased free iron inside the mutant
cells. Since excess free iron is not available in wild type cells, the cells can survive better
with HU, even though HU still generates minimal oxidative stress in wild type cells as
shown by Yap1 activation with HU treatment (120). However, the exact mechanism by
which HU generates oxidative stress remains unclear.
Based on all the data I presented in this thesis, I propose a model, which depicts the two
different HU induced cell killing mechanisms in S. pombe (Fig. 44).
I also found that overexpression of Erg11 can suppress the HU sensitivity of hem13
mutant (Fig. 31). This is not surprising since heme is required for the enzymatic activities
of Erg3, Erg5 and Erg11, highlighting the possible importance of heme for ergosterol
synthesis (138,142). It has been reported that to protect the cells from oxidative stress,
there is strong response from gene products of the ergosterol synthesis pathway (143).
Thus, reduction in heme levels possibly affects the enzymatic activity for the ergosterol
synthesis, required for protecting the cells against oxidative stress. Since ergosterol is a
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sterol similar to cholesterol in humans, it is possible that cholesterol may similarly
provide the resistance to cancer cells against HU.
Apart from hem13 mutant leading to the discovery of novel cell killing mechanism of HU
in S. pombe, my newly identified mutant in the heme biosynthesis pathway led to the
discovery of synergistic effects of the two drugs, HU and SMP, which has great
implications in improving the antifungal therapy. Since my data suggest that hem13
mutant has an underlying deficiency of heme, which leads to its HU sensitivity, I
mimicked this result by inhibition of the heme biosynthesis pathway using SMP and
found that SMP has a synergistic effect with HU in suppressing cell growth in wild type
S. pombe, S. cerevisiae and the pathogenic fungus C. albicans. The CI values (< 0.1) of
various combinations of HU and SMP as determined by Chou and Talalay method
(96,97) suggest strong synergism of the two drugs in all fungi tested. So far, because S.
pombe, S. cerevisiae and C. albicans are phylogenetically distinct, this result suggests
that combination of HU and SMP may suppress cell growth of other pathogenic fungi as
well. Fungal diseases are a global public health problem. About 1.2 billion people
worldwide are estimated to suffer from fungal diseases (144). Most are infections of the
skin, nails or mucosa, but a substantial minority, particularly in individuals who have
weakened immune systems, such as the patients who have cancer or HIV/AIDS, is
invasive or chronic and difficult to treat. It is estimated that 1.5 to 2 million people die of
a fungal infection each year. Most of this mortality is caused by species belonging to four
genera of fungi: Aspergillus, Candida, Cryptococcus and Pneumocystis. Although
effective antifungals such as second generation azoles (ergosterol biosynthesis
inhibitors), echinocandins (cell wall synthesis inhibitor) and amphotericin B (membrane
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Fig 44: Model depicting HU induced cell killing mechanisms in wild type and hem13
mutant in S. pombe
HU, by inhibitng RNR depletes dNTP levels inside the cells, activates the checkpoint
pathway. Under stress conditions induced by HU, the checkpoint responses are absolutely
required for cell survival. Abrogation of the pathway leads to collapsed forks, and DNA
damage leading to cell death. On the other hand, in the presence of heme deficiency and
excess iron inside the cells, HU treatment generates oxidative stress by an unknown
mechanism. The increased oxidative stress, if not properly handled by the cells, leads to
modification of proteins and other macromolecules and eventually cell death.
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pore formation) are available, the toxicity of these drugs and the increasing threat of drug
resistance hamper the effective treatment of fungal infections. Combination therapy using
multiple drugs may tackle these issues associated with the single drug therapy. To this
end, the strong synergistic effect of SMP and HU holds a great potential for the
combination therapy to treat fungal infections. Interestingly, SMP is being tested as one
of the drugs in antifungal pipeline (144). We plan to extend our finding to other known
species of pathogenic fungi such as Aspergillus fumigatus, Histoplasma capsulatum and
Cryptococcus neoformans in search for more effective therapies against fungal diseases.
Because HU has already been used in cancer chemotherapy (1) and SMP can inhibit
heme synthesis in humans (121) and has been shown to kill a human leukemia cell line
by generating ROS (122), our combination therapy using HU and SMP may also have the
potential to be used to treat cancers.
In summary, my work defines that oxidative stress is an underlying cause of HU
sensitivity of hem13 mutant in S. pombe and reveals the strong synergistic effect of HU
and SMP in suppressing cell growth of wild type S. pombe, S. cerevisiae and the
pathogenic fungus C. albicans.
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atg (Autophagy Related genes)
ATM (Ataxia Telangiectasia Mutated)
ATR (ATM -and Rad3-related)
CDK (cyclin dependent kinase)
CI (Combination Index)
CPOX (Coproporphyrinogen Oxidase)
CPT (Camptothecin)
DDR (DNA damage response)
DMSO (Dimethyl sulfoxide)
DNA (deoxyribose nucleic acid)
DNPH (2 4-dinitrophenyl hydrazine)
dNTPs (deoxyribonucleoside triphosphates)
ER (Endoplasmic Reticulum)
ESR (environmental stress response)
FADD (Fas-associated death domain)
H2O2 (Hydrogen peroxide)
HA (hemagglutinin)
HU (hydroxyurea)
IP (immunoprecipitation)
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mM (millimolar)
MMS (Methylmethane Sulfonate)
Mrc1 (mediator of Replication Checkpoint)
nmt (no mRNA in the presence of thiamine)
OD (Optical Density)
ORC (Origin Recognition Complex)
ORF (open reading frame)
PAGE (Polyacrylalmide Gel Electrophoresis)
PCNA (Proliferating Cell Nuclear Antigen)
PI (Propidium Iodide)
PI3K (phosphatidylinositol-3-OH Kinase)
Pkg (Protein Kinase G)
PMSF (Phenylmethylsulfonyl Flouride)
pre-IC (pre-initiation complex)
pre-RC (pre-replication complex)
RNR (Ribonucleotide Reducatse)
ROS (Reactive Oxygen Species)
RPA (Replication Protien A)
SDS (Sodium Dodecyl Sulfate)
SMP (Sampangine)
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